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Abstract
Upon invasion of microbial pathogens, cells of the innate immune system respond through the activation of
pattern recognition receptors (PRRs) that recognize pattern associated molecular patterns (PAMPs). Once
these receptors bind ligand, they initiate a signaling cascade culminating in the expression of proinflammatory
and antiviral cytokines, costimulatory molecules, and antimicrobial agents, all of which contribute to
pathogen clearance and host defense. However, excessive signaling through these receptors can lead to
inflammatory conditions resulting in damage to the host. Therefore, understanding the signaling events
downstream of PRR activation is critical for gaining insight into targeting specific mediators for therapeutic
intervention to combat infection and to limit host pathology. Canonically, Toll-like receptors (TLRs), one
class of PRR, have been thought to signal through serine threonine kinases following ligand recognition.
However, there is emerging evidence for the role of protein tyrosine kinases regulating TLR function, but
their role is not entirely clear. We sought to understand how TLR9 function is affected by a conserved tyrosine
residue in its cytoplasmic domain and by activation of the protein tyrosine kinase Syk. We initially
hypothesized that Syk might be participating in tyrosine phosphorylation of TLR9 to induce downstream
signaling following receptor activation with CpG DNA. Utilizing genetic deletion of Syk in dendritic cells in
vivo and genetic knockdown in a macrophage cell line, here we demonstrate that Syk is important for the
intracellular trafficking and exocytosis of the proinflammatory cytokine TNFa, but not IL-6, following CpG
stimulation. This secretion event involved activation of calcium signaling and calcium calmodulin kinase II
(CaMKII) downstream of Syk. Syk-deficient cells exhibited normal CpG-induced activation of the canonical
TLR9 signaling machinery, suggesting that Syk mediates a signaling cascade to promote cytokine exocytosis
independent of cytokine transcription and translation, a role unexpected based on its function downstream of
ITAM-bearing receptors. These data implicate this signaling pathway in a novel role of cytokine sorting and
may have broader implications for release of other cytokines downstream of various pattern recognition
receptors.
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ABSTRACT 
TYROSINE PHOSPHORYLATION AND STRUCTURAL REQUIREMENTS MEDIATE 
TOLL-LIKE RECEPTOR 9 FUNCTION 
Sheila Rao 
Edward M. Behrens 
Gary A. Koretzky 
 
Upon invasion of microbial pathogens, cells of the innate immune system 
respond through the activation of pattern recognition receptors (PRRs) that recognize 
pattern associated molecular patterns (PAMPs). Once these receptors bind ligand, they 
initiate a signaling cascade culminating in the expression of proinflammatory and 
antiviral cytokines, costimulatory molecules, and antimicrobial agents, all of which 
contribute to pathogen clearance and host defense. However, excessive signaling 
through these receptors can lead to inflammatory conditions resulting in damage to the 
host. Therefore, understanding the signaling events downstream of PRR activation is 
critical for gaining insight into targeting specific mediators for therapeutic intervention to 
combat infection and to limit host pathology. Canonically, Toll-like receptors (TLRs), one 
class of PRR, have been thought to signal through serine threonine kinases following 
ligand recognition. However, there is emerging evidence for the role of protein tyrosine 
kinases regulating TLR function, but their role is not entirely clear. We sought to 
understand how TLR9 function is affected by a conserved tyrosine residue in its 
cytoplasmic domain and by activation of the protein tyrosine kinase Syk. We initially 
hypothesized that Syk might be participating in tyrosine phosphorylation of TLR9 to 
induce downstream signaling following receptor activation with CpG DNA. Utilizing 
genetic deletion of Syk in dendritic cells in vivo and genetic knockdown in a macrophage 
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cell line, here we demonstrate that Syk is important for the intracellular trafficking and 
exocytosis of the proinflammatory cytokine TNFα, but not IL-6, following CpG 
stimulation. This secretion event involved activation of calcium signaling and calcium 
calmodulin kinase II (CaMKII) downstream of Syk. Syk-deficient cells exhibited normal 
CpG-induced activation of the canonical TLR9 signaling machinery, suggesting that Syk 
mediates a signaling cascade to promote cytokine exocytosis independent of cytokine 
transcription and translation, a role unexpected based on its function downstream of 
ITAM-bearing receptors. These data implicate this signaling pathway in a novel role of 
cytokine sorting and may have broader implications for release of other cytokines 
downstream of various pattern recognition receptors. 	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Chapter 1	  
Introduction	  	  
	  
Innate recognition of microbial products: A historical perspective  
The late Charles Janeway, one of the leading immunologists of his generation, 
proposed a theory on pattern recognition which provided a conceptual framework for 
understanding the role of innate immunity and how it activated the adaptive immune 
response (Janeway, 1989). At the time, it was known that microbial stimuli could induce 
macrophage function (Steinman and Moberg, 1994), and that poly IC, a synthetic analog 
of pathogenic RNA, activated type I interferon genes (Nagata et al., 1980). However, 
integration between innate and adaptive immunity was not well appreciated, and studies 
on either system were occurring independently of others. In his publication, Janeway 
hypothesized that costimulatory signals activating lymphocytes were induced by 
conserved microbial products. These agents, termed pathogen-associated molecular 
patterns (PAMPs), were proposed to be recognized by germline-encoded receptors, 
distinct from the gene-rearranged receptors expressed by T and B lymphocytes. 
Furthermore, Janeway suggested that adjuvants “trick” the cells of the adaptive immune 
system into activation by first inducing costimulatory molecules via innate immune 
receptors. While his theory was overlooked at first, subsequent discoveries elucidating 
pattern recognition pathways validated Janeway’s hypotheses.  
It was postulated that cell surface receptors would recognize PAMPs and induce 
expression of costimulatory molecules via Rel-type transcription factors. Nuclear factor 
kappa-light-chain-enhancer of activated B cells (NF-κB) was known to play a role in the 
innate immune response (Kopp and Ghosh, 1995), and one such receptor known to 
activate this molecule was the interleukin-1 (IL-1) receptor. Interestingly, the IL-1 
receptor contained a cytoplasmic domain with structural homology to the Toll receptor 
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identified in Drosophila (Hashimoto et al., 1988). Proteins demonstrating homology to 
this TIR (Toll, IL-1R and resistance protein) domain were identified from a National 
Center for Biotechnology Information (NCBI) database in the mid-1990s (Nomura et al., 
1994), and ultimately Toll like receptor (TLR) 4, homologous to the Drosophila Toll, was 
cloned and isolated.  Consistent with a role in innate immune responses, this receptor 
demonstrated the ability to activate NF-κB. An exciting discovery was made soon after 
describing an antifungal role for the Drosophila Toll, suggesting that perhaps the 
mammalian Toll-like receptor would also play a role in immune function and activate 
costimulatory molecules (Lemaitre et al., 1996). Indeed, Medzhitov and Janeway 
demonstrated that the constitutively active human homologue of Toll could induce 
expression of the cytokines IL-1, IL-6, and IL-8 and the costimulatory molecule B7.1 
(Medzhitov et al., 1997). Subsequently, other Toll-like receptors (Chuang and Ulevitch, 
2000; Rock et al., 1998) and their ligands (Takeda et al., 2003) were identified.  
In addition to TLRs, other receptors engaging microbial products and their 
functions were discovered. These include NOD1 (Inohara et al., 1999) and NOD2, 
cytosolic sensors of bacterial peptidoglycans (Chamaillard et al., 2003; Girardin et al., 
2003a; Girardin et al., 2003b; Inohara et al., 2003). The fungal component β-glucan was 
found to trigger the receptor Dectin-1 (Brown and Gordon, 2001). In 2004, the cytosolic 
sensors of double-stranded RNA, RIG-I and MDA-5, were identified (Yoneyama et al., 
2004). Subsequent studies of these receptors demonstrated important roles in immune 
recognition and host defense. 
Activation of these pattern recognition receptors triggers the adaptive immune 
system by the upregulation of costimulatory molecules and through the secretion of 
effector cytokines. These studies provided experimental evidence that Janeway’s 
hypothesis was correct. Because of the essential role these receptors play in innate and 
adaptive immune responses, it is important to continue to study their signaling properties 
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and functions. It is likely that new receptors and new mechanisms of immune activation 
will be uncovered with further investigation. 
 
The biology of Toll-like receptors 
 As Janeway predicted, pattern recognition receptors contribute to the activation 
of adaptive immunity by causing the upregulation of costimulatory molecules on antigen 
presenting cells, like dendritic cells (DCs). In addition to their ability to upregulate 
expression of CD80 and CD86, pattern recognition receptors also signal for the 
production of chemokines and proinflammatory cytokines, including IL-6, IL-12, and 
tumor necrosis factor alpha (TNFα). Upon secretion, these effectors contribute to the 
immune response by recruiting other cells of the innate immune system, like monocytes 
and neutrophils, facilitating differentiation of T lymphocytes, activating phagosomal lysis 
of pathogens, and promoting inflammation. While these responses are crucial for host 
defense, excessive signaling through these receptors can lead to inflammatory 
conditions. Discussed below is the role of one type of PRR, TLRs, in pathogen clearance 
and in inflammatory conditions.  
 TLRs are type I transmembrane proteins containing a leucine rich repeat domain 
for pathogen recognition and a cytoplasmic TIR domain mediating downstream 
signaling. These receptors are primarily expressed by cells of the hematopoetic system, 
including the innate immune cells macrophages and DCs. There are ten TLRs present in 
humans and twelve expressed in mice. Each TLR is triggered by a different PAMP. 
These PAMPs include nucleic acids, lipoproteins, lipids, and proteins derived from such  
pathogens as viruses, bacteria, and fungi. TLRs gain access to their ligands via their 
localization within the cell. For example, nucleic acids are recognized by the endosomal 
TLRs, TLRs 3, 7, 8, and 9, while other PAMPs activate the cell surface receptors, TLRs 
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1, 2, 4, 5, 6, 11, 12, and 13. Compartmentalization of TLRs offers a useful strategy for 
regulation of the initiation of appropriate immune responses (Barton and Kagan, 2009). 
 
Toll-like receptors in host defense 
 Numerous studies utilizing mice deficient in various TLRs have uncovered a 
central role for these receptors in host cell recognition and defense against microbial 
pathogens, including bacteria, viruses, fungi, protozoa, and parasites. As noted above, 
their activation results in the production of proinflammatory cytokines and antiviral 
molecules that aid in pathogen clearance by recruiting cells of the innate immune system 
and by stimulating pathogen-specific adaptive immunity. Mice lacking these receptors or 
adaptor molecules associated with TLR signaling have severe defects in their ability to 
control certain pathogens, often resulting in death. 
 Bacteria contain a variety of PAMPs, including nucleic acids, LPS, lipopeptides, 
and flagellin, that trigger many different TLRs. TLR4-mutant mice are impaired in their 
ability to clear mycobacterium from the lungs, and expression of proinflammatory 
cytokines and chemokines is reduced in the lungs of these mice, demonstrating a role 
for TLR4 in the control of Mycobacterium tuberculosis (Abel et al., 2002). TLR4-deficient 
mice are also more susceptible to Salmonella typhimurium infection (Weiss et al., 2004). 
Furthermore, the Weiss study demonstrated that mice deficient in both TLR2 and TLR4 
succumb to infection even earlier than TLR4 knockouts, implicating cooperation between 
the two receptors for maximal control of S. typhimurium. More recently, TLR11 was 
shown to be important in the control of this bacterium, as TLR11-/- mice demonstrated 
greater dissemination of Salmonella into the spleen and liver (Shi et al., 2012). In this 
model, TLR11 was proposed to prevent penetration of the bacterium into the Peyer’s 
patches, thereby blocking systemic propagation into host organs. Mice lacking TLR1 had 
reduced survival following oral infection with Yersinia enterocolitica due to a defect in 
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their ability to induce differentiation of T helper 17 cells for pathogen clearance (DePaolo 
et al., 2012).  
 TLRs are also critical for their role in antiviral immunity. Strong inducers of 
antiviral molecules like type I interferons (IFN) include the nucleic acid sensing 
receptors, TLR3, TLR7, TLR8, and TLR9. TLR9 expression is necessary for cytokine 
responses to herpes simplex virus 1 (HSV1) in vitro (Lund et al., 2003), and TLR9 
knockout mice inefficiently controlled replication of mouse cytomegalovirus (MCMV) in 
vivo (Krug et al., 2004; Tabeta et al., 2004). The Tabeta study also revealed a role for 
TLR3 in host defense against MCMV, suggesting redundancy in the ability of TLRs to 
mount an antiviral response against this pathogen. The ligand for TLR7 is single 
stranded RNA, and mice deficient in TLR7 demonstrated reduced serum IFNα levels in 
vivo after infection with either the single stranded RNA viruses vesicular stomatitis virus 
or influenza virus (Lund et al., 2004). These studies demonstrate the importance of TLRs 
in antiviral immunity for their induction of proinflammatory cytokines and their ability to 
activate cells of the adaptive immune system to assist in pathogen control.  
 Infection with protozoa including Leishmania, Trypanosoma cruzi, Trypanosoma 
brucei, Plasmodium, and Toxoplasma gondii accounts for immeasurable human 
suffering and is a major health issue world wide. Parasitic PAMPs, including 
glycosylphosphatidylinositol (GPI) anchors, genomic DNA, and profilin, can activate host 
defense via TLR recognition (Gazzinelli and Denkers, 2006). Mice deficient in TLR12, 
shown to recognize profilin, are highly susceptible to infection with Toxoplasma gondii 
(Koblansky et al., 2013). TLR12-induced production of IL-12 was necessary to trigger 
NK cell secretion of IFNγ to combat the pathogen. TLR11 also recognizes T. gondii 
profilin, but TLR11 knockout mice survived infection with this pathogen (Yarovinsky et 
al., 2005). This can be explained by the ability of TLR12 to heterodimerize with TLR11 or 
to homodimerize for recognition of parasitic profilin (Koblansky et al., 2013).  
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 DNA from T. cruzi stimulates bone marrow derived macrophages in a TLR9-
dependent manner, while TLR2 is necessary for recognition of GPI anchors (Bafica et 
al., 2006). Consistent with these in vitro data, mice deficient in both TLR2 and TLR9 
succumb to T. cruzi infection, suggesting cooperation between these two receptors in 
parasite control. TLR9 also plays a role in control of parasitemia in vivo in mice infected 
with T. brucei (Drennan et al., 2005). Mice deficient in myeloid differentiation primary 
response protein 88 (MyD88), an adaptor molecule utilized by all TLRs except TLR3, 
demonstrate impaired cytokine responses and increased susceptibility to L. major (de 
Veer et al., 2003; Muraille et al., 2003), T. brucei (Drennan et al., 2005), T. cruzi 
(Campos et al., 2004), and T. gondii (Scanga et al., 2002), suggesting the importance of 
TLR signaling for the control of parasitic infection.  
 As reported above, it is evident that TLRs play a central role in host defense 
against a variety of invading pathogens. However, excessive signaling through TLRs can 
result in inflammatory conditions and host tissue damage. Therefore, understanding the 
signaling molecules that regulate TLR signaling is crucial for identifying targets for 
therapeutic intervention to ensure appropriate responses. Below, we discuss canonical 
and noncanonical signaling intermediates that participate in the control of cytokine 
responses downstream of TLR ligand recognition. 
  
Toll-like receptor signaling 
 Upon ligand recognition, TLRs signal through two adaptor molecules, TIR 
domain-containing adaptor inducing IFNβ (TRIF) and MyD88. TLR4 is the only TLR that 
signals through both adaptors. All of the other TLRs signal through MyD88, except for 
TLR3, which utilizes only the TRIF signaling pathway. The receptors can bind TIR 
domain-containing adaptor protein (TIRAP)/Mal and MyD88 via TIR-TIR interactions 
resulting in activation of downstream signaling (Jiang et al., 2006). This interaction 
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recruits interleukin-1 receptor-associated kinase (IRAK) (Nunez Miguel et al., 2007). The 
IRAK family members become serine/threonine phosphorylated and subsequently 
dissociate from MyD88 in order to activate tumor necrosis factor receptor-associated 
factor 6 (TRAF6). TRAF6 exerts its function by ubiquitinating transforming growth factor-
β-activated protein kinase 1 (TAK1). Ubiquitination is yet another post-translational event 
that can mediate signal transduction (Chen, 2005). Upon forming a complex with other 
proteins, ubiquitinated TAK1 activates the IκB kinase (IKK) complex, which results in 
phosphorylation and degradation of IκBα leading to nuclear translocation of the 
transcription factor NF-κB. TAK1 can also serine/threonine phosphorylate members of 
the mitogen activated protein kinase (MAPK) family, leading to phosphorylation and 
activation of c-Jun N-terminal kinase (JNK), p38, and extracellular signal-regulated 
kinase (Erk). These molecules, along with NF-κB, contribute to transcriptional activation 
of proinflammatory cytokines, like IL-6, IL-12, and TNFα. Throughout this thesis, we will 
refer to the canonical TLR9 signaling pathway as depicted in Figure 1.1. 
 The other TLR adaptor molecule, TRIF, signals downstream of TLR3 and TLR4 
with the help of TRIF-related adaptor molecule (TRAM) (Yamamoto et al., 2003b). Like 
MyD88, TRIF can also activate NF-κB through its recruitment of TRAF6. Through 
activation of noncanonical IKKs, interferon regulatory factors (IRFs) are phosphorylated, 
resulting in transcription of type I IFNs. Indeed, TRIF-deficient mice showed defective 
type I IFN production in response to LPS, while MyD88 signaling remained intact (Hoebe 
et al., 2003; Yamamoto et al., 2003a). 
 Canonically, the kinases identified downstream of TLRs participate in 
serine/threonine phosphorylation events. However, there is accumulating evidence for a 
role for tyrosine kinases in the regulation of TLR signaling. Receptor tyrosine 
phosphorylation induces signaling downstream of TLR2 (Arbibe et al., 2000; Xiong et al., 
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2012), TLR3 (Sarkar et al., 2004), TLR4 (Medvedev et al., 2007), TLR5 (Ivison et al., 
2007), and TLR9 (Sanjuan et al., 2006). These reports suggest that tyrosine 
phosphorylation of the receptor itself mediates downstream signaling upon ligand 
recognition. Furthermore, the mutation identified in the C3H/HeJ mice, rendering the 
animals non-responsive to LPS (Poltorak et al., 1998), prevents TLR4 phosphorylation 
and results in abrogated downstream signaling in vitro (Medvedev et al., 2007). 
Additionally, the adaptor Mal is tyrosine phosphorylated in response to LPS, and 
mutations of tyrosine residues in its TIR domain prevented LPS-induced activation of 
p38 and NF-κB (Gray et al., 2006; Piao et al., 2008). Because of these reports 
implicating phosphorylation of the receptor as an event initiating downstream signaling, 
some groups focused on identifying the potential kinase(s) involved. It was reported that 
treatment of a human monocytic cell line (THP-1) with a pharmacological inhibitor of 
spleen tyrosine kinase (Syk) prevented LPS-induced phosphorylation of TLR4 
(Chaudhary et al., 2007). However, it is known that Syk inhibitors can lead to off-target 
effects and prevent activity of other kinases (Geahlen and McLaughlin, 1989; Lin et al., 
2010). Therefore, it is possible that a kinase other than Syk was responsible for TLR4 
tyrosine phosphorylation in that system. Vogel’s group demonstrated that in a 
heterologous expression system the Src family kinase Lyn associated with TLR4, and 
Src inhibition resulted in reduced TLR4 phosphorylation in response to LPS (Medvedev 
et al., 2007). Similarly, treatment of THP-1 cells with Src family kinase or Syk inhibitors 
results in abrogated CpG-induced TLR9 phosphorylation (Sanjuan et al., 2006). Sen’s 
group reported that the tyrosine kinase phosphoinositide kinase-3 (PI3K) associated with 
TLR3 in transfected HEK 293 T cells, suggesting that PI3K participates in the 
phosphorylation of TLR3 (Sarkar et al., 2004). It will be important to validate these 
results with endogenous proteins and genetic deletion to prevent potential nonspecific 
interactions seen in heterologous expression systems and to avoid off-target effects of 
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pharmacological inhibition. Nonetheless, these studies provide evidence to implicate the 
involvement of tyrosine kinases in the initiation of TLR signaling. 
 
Tyrosine kinase function downstream of TLRs 
 In addition to tyrosine phosphorylation events of the receptor mediating TLR 
signaling, there are also reports implicating tyrosine kinases in the regulation of 
downstream signaling. For example, PI3K, whose activation depends on tyrosine 
phosphorylation, was implicated in TLR2-mediated activation of NF-κB by way of Rac1 
GTPase independent of IκBα (Arbibe et al., 2000). Pharmacologic inhibition of PI3K 
resulted in decreased secretion of TLR4-induced monocyte chemoattractant protein-1 
(MCP-1) in human neutrophils (Arndt et al., 2004). Moreover, genetic deletion or 
knockdown of PI3K prevented LPS-induced secretion of TNFα in macrophages (Low et 
al., 2010).  
Bruton’s tyrosine kinase (BTK) was tyrosine phosphorylated following LPS 
stimulation and interacted with TLR4, MyD88, and IRAK-1. Introduction of a dominant 
negative BTK abrogated LPS-induced NF-κB activation (Jefferies et al., 2003). Its 
association with TLR4 suggests that BTK might also participate in phosphorylation of the 
receptor following ligand recognition. BTK also interacted with TLR2, and its inhibition 
resulted in reduced mRNA expression of some cytokines in a mouse macrophage cell 
line (Liljeroos et al., 2007). In B cells, CpG stimulation of TLR9 caused BTK 
phosphorylation, and BTK-deficient B cells demonstrated increased levels of secreted 
IL-12, suggesting specific negative regulation of this cytokine (Lee et al., 2008). It is 
important to note that the Liljeroos study utilized pharmacologic inhibition of BTK, the 
potential off-targets of which could confound the interpretation of the results. It will be 
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important to extend genetic deletions of this molecule to studies investigating BTK 
function in innate immune cells. 
 LPS stimulation of bone marrow derived DCs (BMDCs) caused tyrosine 
phosphorylation of the Src family kinases Lyn, Hck, and Fyn, and CD45-deficient cells 
demonstrated dysregulation of the activation of these proteins (Cross et al., 2008). 
Furthermore, this study found dysregulated cytokine secretion in response to various 
TLR ligands, but normal activation of the signaling molecules MAPKs and Akt. However, 
the link between Src family kinase phosphorylation and cytokine secretion remains to be 
determined. Expression of Src family kinases was abolished in Lyn-deficient bone 
marrow derived DCs, and these cells demonstrated reduced maturation, based on CD86 
and CD40 surface expression, in response to LPS, CpG, and poly IC (Chu and Lowell, 
2005). Secretion of IL-12 was abrogated in the absence of Lyn, while TNFα and IL-6 
levels were normal. The mechanism by which Lyn exerts its effects on IL-12, however, 
was not investigated in this study. More recently, it was reported that myeloid 
differentiation factor-2 (MD-2), a component of the LPS receptor complex, was tyrosine 
phosphorylated and interacted with Lyn kinase in the endosome (Gray et al., 2011). The 
implication is that Lyn phosphorylated MD-2 prior to its trafficking to the plasma 
membrane. Mutation of MD-2 tyrosine residues resulted in reduced LPS-induced IL-8 
secretion with only a modest defect in NF-κB activity. It is possible that MD-2 tyrosine 
phosphorylation initiates a signaling cascade to export IL-8 out of the cell after its 
synthesis. It will be interesting to investigate how MD-2 tyrosine phosphorylation or the 
absence of Lyn affects protein translation of cytokines in addition to their secretion. 
 The protein tyrosine kinase Syk has also been implicated in signaling 
downstream of TLRs. Activation of TLR4 by minimally oxidized low-density lipoprotein 
(mmLDL) in macrophages resulted in phosphorylation of Syk and its downstream target 
phospholipase C gamma (PLCγ) independent of MyD88, resulting in generation of 
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reactive oxygen species (ROS) (Bae et al., 2009). Knockdown of Nox2, downstream of 
Syk and PLCγ activation, caused a defect in ROS generation and a reduction in 
production of only some cytokines, including IL-6 and IL-1β, while production of TNFα, 
MCP-1, and macrophage inflammatory protein 1 alpha (MIP1α) was unaffected. These 
data suggest that Syk-dependent ROS generation differentially regulates cytokine 
production in response to mmLDL in macrophages. Cliff Lowell’s group reported that 
neutrophil-specific deletion of Syk resulted in impaired TNFα secretion, while mRNA 
production was intact, in response to opsonized bacteria, suggesting a role for Syk in 
TNFα exocytosis (Van Ziffle and Lowell, 2009). Furthermore, studies with Syk inhibitors 
resulted in reduced TLR-induced cytokine secretion (Chaudhary et al., 2007). 
However, Syk has also been implicated in the negative regulation of TLR 
responses. Cao’s group reported that TLR-induced integrin activation resulted in Syk 
phosphorylation that mediated the degradation of TLR adaptor molecules to dampen the 
TLR response (Han et al., 2010). Additionally, Syk deficient bone marrow derived DCs 
demonstrated increased cytokine secretion in response to TLR ligands (Hamerman et 
al., 2005). The interpretation of this study was that TLR signals activate the 
immunoreceptor tyrosine-based activation motif  (ITAM)-bearing adaptor molecule 
DAP12. This leads to Syk recruitment and phosophorylation resulting in its suppressive 
effect on TLR signaling. However, the mechanism by which Syk acts on the TLR 
pathway was not identified in this study, and the use of Syk KO cells could have resulted 
in developmental defects in DCs, possibly confounding the interpretation of the results. It 
will be important to utilize cell-specific deletions or conditional knockouts of Syk to 
ensure normal development of these cells to investigate Syk function.  
Historically, the canonical TLR pathway leading to cytokine responses involves 
signaling through serine/threonine kinase events, and secretion of these cytokines has 
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been linked to the signaling machinery itself. Most investigators have focused on 
cytokine transcription and translation as the critical events driving cytokine secretion. Of 
course, after cytokine translation, there necessarily must be some mechanism by which 
the cytokine moves to the outside of the cell to be secreted. As noted above, there is 
emerging evidence for a role of tyrosine kinases in the regulation of TLR responses, and 
many studies point to these non-canonical signaling molecules in the regulation of 
cytokine vesicle transport (Kamen et al., 2011; Low et al., 2010; Nanamori et al., 2007). 
Therefore, it is possible that PAMP recognition elicits a distinct pathway necessary for 
cytokine exocytosis that relies on tyrosine kinases in addition to the canonical 
serine/threonine kinase pathway resulting in cytokine transcription. Discussed below is a 
review on cytokine exocytosis. 
 
Regulation of cytokine responses 
As mentioned previously, TLRs signal for the production of cytokines, which can 
facilitate the immune response by recruiting other immune cells to the site of infection or 
by contributing to the differentiation of T helper cells, among numerous other functions. 
However, aberrant TLR signaling can lead to inappropriate cytokine responses and 
subsequent tissue damage and inflammatory conditions. Therefore, gaining an 
understanding of the signaling events and mechanisms by which cells control the export 
of cytokines is critical for identifying possible therapeutic targets to shape the immune 
response. Discussed below is a review of cytokine secretion pathways.  
Most cytokines are secreted via the classic secretory pathway, in which proteins 
traffic through the endoplasmic reticulum (ER) and are packaged in the Golgi apparatus 
into vesicles for their transport out of the cell (Stanley and Lacy, 2010). Classical 
secretion can be divided into two categories: regulated exocytosis and constitutive 
exocytosis. Constitutive exocytosis of cytokines is defined by de novo transcription of the 
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cytokine following receptor stimulation, like that from TLRs, cytokine receptors, Fc 
receptors, and other PRRs, among others. Once the cytokine is transcribed and 
translated, a coordinated series of events occurs allowing for appropriate packaging and 
trafficking of the cytokine to ensure proper exocytosis. Regulated exocytosis of cytokines 
is defined as signal-mediated release and secretion of vesicles containing preformed 
cytokine in the absence of de novo cytokine transcription. In this mode of exocytosis, 
cytokines are already packaged into vesicles in a resting cell and are released within 
minutes of a specific receptor engagement. Orchestrating the movement of many 
different cargo molecules to achieve the desired cytokine response involves an array of 
trafficking machinery, including soluble N-ethylmaledimide-sensitive factor attachment 
protein receptors (SNAREs), cytoskeleton motor proteins, golgins, and the Rab and Rho 
proteins (Stanley and Lacy, 2010). SNAREs mediate the fusion of membranes on the 
donor cargo-containing vesicle with a target membrane, either from another endosomal 
vesicle or the plasma membrane, to release the contents. As discussed below, these 
proteins can participate in the differential sorting and transport of cytokines and 
chemokines throughout the cell. It is important, therefore, to elucidate the trafficking 
machinery and pathways required to transport individual cytokines from the cell to 
adequately understand how immune responses are generated.   
Mast cells, eosinophils, and neutrophils are examples of cell types that 
participate in regulated exocytosis of cytokines. For example, mast cells can release 
secretory granules containing preformed cytokine in response to Fc receptor ligation, a 
process known as degranulation, in the absence of de novo transcription (Gordon and 
Galli, 1990; Tiwari et al., 2008). Fusion of these granules, depending on the cargo, can 
be differentially regulated. For example, deletion in a specific SNARE molecule, vesicle 
associated membrane protein (VAMP)-8, resulted in impaired Fc-epsilon-induced 
release of serotonin and cathepsin D, but not of TNFα (Puri and Roche, 2008). Instead, 
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TNFα localized with VAMP3 at the cell surface in mast cells (Tiwari et al., 2008). Indeed, 
several molecules have been described in differential vesicular trafficking in mast cells 
(Lorentz et al., 2012). Interestingly, inhibition of PI3K, whose activation depends on 
phosphorylation of its tyrosine residues, resulted in diminished phosphorylation of 
trafficking proteins in mast cells, suggesting a role for tyrosine kinase substrates in 
vesicular transport (Nanamori et al., 2007). Additionally, tyrosine phosphorylated 
proteins were identified in degranulating neutrophils and thought to participate in 
exocytosis (Luerman et al., 2011), and neutrophils deficient in proline rich kinase 2 
(Pyk2) were unable to degranulate downstream of integrin activation (Kamen et al., 
2011). These studies suggest that individual cytokines depend on a specific set of 
trafficking molecules for their degranulation and exocytosis in mast cells and neutrophils 
and that tyrosine kinases can facilitate this process. 
Constitutive release of cytokines has been well described in macrophages. 
Similar to what has been observed in mast cells during regulated exocytosis, 
macrophages also utilize a wide array of trafficking molecules to export various 
cytokines and chemokines after receptor-induced transcription. Endosomal vesicles 
carrying distinct cargo molecules rely on expression of various components of the 
trafficking machinery, including SNAREs, Rab GTPases, and golgins. Upregulation of 
several different SNARE molecules, including syntaxin 7, VAMP3, VAMP8, syntaxin 6, 
Vti1b, syntaxin 4, syntaxin 3, and SNAP 23, among others, has been reported in 
macrophages after TLR stimulation (Achuthan et al., 2008; Han et al., 2009; Murray et 
al., 2005a; Murray et al., 2005b; Pagan et al., 2003). Rab GTPase proteins have also 
been identified for their role in constitutive exocytosis in macrophages and participate in 
formation of vesicle membranes and the fusion of vesicles to target membranes for 
cargo release (Hutagalung and Novick, 2011). The golgin family of molecules is 
expressed at the Golgi complex and function by forming vesicular carriers and by 
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tethering vesicles to the Golgi membrane. The golgins p230 and golgin-97 participate in 
macrophage constitutive exocytosis (Lieu et al., 2008; Stanley et al., 2012). These 
molecules are induced during TLR stimulation and assist with cargo loading and 
endosomal trafficking to ensure appropriate packaging and release of cytokines. 
Because cytokines can exert profound effects on both host defense and damage to host 
tissues, it is likely that secretion of these molecules must be exquisitely regulated by 
numerous trafficking intermediates to achieve the desired response.  
TNFα, a potent proinflammatory cytokine, has many post-translational regulators 
that facilitate in its secretion from the cell. The mechanism of TNFα transport has been 
most closely investigated in macrophages participating in constitutive exocytosis. Once 
TNFα is synthesized as a membrane-bound protein in the ER in response to a stimulus, 
it is packaged in the Golgi complex into tubulovesicular structures (Shurety et al., 2000). 
Loading of the cytokine into vesicles and its subsequent entry into the endosomal 
compartment are regulated processes involving many members of the trafficking 
machinery. TNFα colocalized with the golgin p230 at the Golgi, and knockdown of p230 
resulted in diminished trafficking of LPS-induced TNFα in macrophages (Shurety et al., 
2000). Following packaging, TNFα-containing vesicles must be released from the Golgi 
membranes to enter the trafficking pathway to the cell surface. Deletion of the δ isoform 
of PI3K or the GTPase dynamin 2 caused these vesicles to remain tethered to the Golgi 
membrane, thereby preventing secretion of TNFα in response to LPS (Low et al., 2010). 
Interestingly, IL-6 secretion was unaffected by the absence of PI3K, suggesting that this 
kinase is involved in the regulation specifically of TNFα transport in macrophages. 
Indeed, because such a diverse array of molecules traffics from this organelle, regulation 
must be tightly coordinated to ensure the appropriate response is being generated. Thus 
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it is not surprising that generation of a coordinated immune response relies on regulation 
of so many different trafficking intermediates (De Matteis and Luini, 2008). 
Once TNFα vesicles detach from the Golgi membrane, they must fuse with 
membranes of trafficking endosomes, another highly regulated process. Fractionation 
studies in LPS-stimulated macrophages demonstrated that budded vesicles (shown to 
be recycling endosomes) contained TNFα, syntaxin 6, and vt11b (Murray et al., 2005b). 
Additionally, VAMP3 knockdown resulted in diminished TNFα secretion, and TNFα 
colocalized with Rab11 in recycling endosomes (Murray et al., 2005a). TLR-induced 
upregulation of secretory carrier membrane protein-5 (SCAMP5) promoted TNFα 
trafficking from the Golgi to the cell surface (Han et al., 2009). SCAMP5 interacted with 
many different SNARE molecules, and its knockdown prevented LPS-induced TNFα 
secretion. Rab27 and Munc13-1 were also reported to interact in recycling endosomes 
and to promote TNFα secretion (Mori et al., 2011). Interestingly, TNFα and IL-6 were 
loaded into different vesicles at the Golgi complex (Manderson et al., 2007). These 
investigations suggest that a complex network of trafficking proteins is important for 
cytokine exocytosis in response to TLR stimulation and that these molecules can 
differentially sort cytokines to regulate their transport.  
Prior to its secretion, TNFα is delivered to the plasma membrane as an integral 
membrane protein and must be cleaved at the cell surface such that soluble cytokine is 
released into the extracellular space. This is achieved by TNFα-converting enzyme 
(TACE) / ADAM17 (Black et al., 1997). Even TACE trafficking is regulated to ensure 
appropriate release of TNFα (Adrain et al., 2012; McIlwain et al., 2012). The fusion of 
TNFα-containing endosomes with the plasma membrane also relies on coordinated 
activity of the SNARE machinery. Syntaxin 4 associated with cholesterol-rich lipid rafts at 
the plasma membrane to form a phagocytic cup structure to which VAMP3 endosomes 
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containing TNFα were delivered following LPS stimulation (Kay et al., 2006). TACE also 
colocalized with these molecules at phagocytic cups to guarantee cleavage and release 
of TNFα (Murray et al., 2005a).  
Trafficking pathways have also been described for the exocytosis of other 
cytokines. IL-6, a soluble cytokine, was reported to rely on similar SNARE molecules as 
TNFα, but these cytokines could be sorted into different vesicles at the Golgi complex 
(Manderson et al., 2007). Furthermore, in contrast to TNFα, IL-6 vesicles were not 
directed to the phagocytic cup at the cell surface. These data suggest that undefined 
molecules might participate in the differential sorting of these two cytokines at the Golgi 
complex. While several molecules have been described for cytokine exocytosis in 
macrophages, additional work remains to be done regarding the differential regulation of 
these intermediates to achieve a specific cytokine response. Because these cytokines 
impose disparate effects on the immune response, understanding how they are sorted 
and trafficked will uncover potential targets for therapeutic intervention.  
 
Structure of thesis 
 This thesis examines how tyrosine phosphorylation events affect signaling 
downstream of TLR9. In particular, we are interested in the protein tyrosine kinase Syk 
and TLR9 itself as a potential substrate for tyrosine phosphorylation. Syk 
phosphorylation has been reported in response to TLR3, TLR4, and TLR9 stimulation 
(Han et al., 2010), but the exact role of this kinase in TLR signaling is unresolved. 
Conflicting reports in the literature portray Syk as a negative regulator of TLR signaling 
or as a positive regulator of TLR signaling. Many of these studies have utilized 
pharmacological inhibition of Syk, which may impose off-target effects and affect kinases 
other than Syk. Moreover, groups utilizing Syk knockout (KO) cells might be imposing 
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developmental defects in cells due to the absence of Syk. Therefore, in order to more 
rigorously investigate the role of this kinase in TLR signaling, we have emplyed genetic 
knockdown in a macrophage cell line and utilizied genetic deletion of Syk in dendritic 
cells in vivo. These approaches avoid potential off-target effects of inhibitors and allow 
cells to develop in the presence of Syk, thus preventing developmental defects. In 
Chapter II, we investigate the role of Syk downstream of CpG-induced activation of 
TLR9 using these genetic approaches. The data presented in this Chapter suggest that 
Syk positively mediates CpG-induced signaling by promoting the trafficking of TNFα, but 
not IL-6, to the cell surface. These experiments suggest that Syk participates in the 
differential secretion of cytokines and that TLR ligands must promote a signal for 
transport to the plasma membrane distinct from the signal leading to cytokine 
transcription in order to activate cytokine exocytosis completely. This was an unexpected 
finding because in other signaling systems, for example downstream of the B cell 
receptor, tyrosine kinases including Syk play a critical role in regulating proximal 
signaling events ultimately affecting gene transcription. However, here, we find that Syk 
is participating outside the canonical TLR9 signaling pathway to promote TNFα 
exocytosis. In Chapter III of this thesis, we address the biochemical mechanism by 
which Syk regulates TNFα exocytosis in response to CpG. Because calcium mobilization 
is a known downstream effector of Syk in other signaling systems (Mocsai et al., 2010), 
we ask if Syk-dependent calcium signals can promote TNFα secretion in response to 
CpG. Indeed, the data presented in this Chapter demonstrate that calcium calmodulin 
kinase II (CaMKII) is the target of Syk-dependent calcium signaling that facilitates TNFα 
exocytosis.  
 During the course of our studies investigating Syk function in TLR9 signaling, we 
became interested in the receptor itself as a potential modulator of downstream 
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signaling. Posttranslational modification of TLR9, including receptor proteolysis and 
phosphorylation, to promote downstream signaling has been previously reported. 
Though preliminary, we show data in Chapter IV to suggest that a conserved tyrosine 
residue in the TIR domain of TLR9 is important for receptor activation. When mutated to 
phenylalanine, the receptor cannot mature as efficiently, suggesting that tyrosine 
phosphorylation might be a mechanism by which TLR9 becomes fully activated to exert 
its effects. Further experimentation will be needed to confirm the effects of TLR9 
phosphorylation in downstream signaling.  
 In the final Chapter of the thesis, we discuss the significance of our findings for 
our understanding in tyrosine kinase-induced regulation of cytokine responses. 
Additionally, we propose future investigations to explore based on our results.   
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Figure 1.1 The canonical TLR9 signaling pathway. Canonically, upon CpG 
stimulation, TLR9 signals through the adaptor molecule MyD88. MyD88 recruitment 
leads to the activation of NF-κB and the MAPKs, Erk and p38. This leads to the 
transcription of proinflammatory cytokines including IL-6 and TNFα.
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Chapter II 
Results 
Syk mediates trafficking of TNFα  downstream of CpG signaling in innate  
immune cells 
 
Introduction 
Pattern recognition receptors, including Toll-like receptors, triggered by PAMPs activate 
a variety of signaling events leading to initiation of the immune response (Takeda et al., 
2003). This response includes upregulation of costimulatory molecules on innate 
immune cells, production of antiviral molecules and proinflammatory cytokines, and 
activation of antigen-specific immunity. While TLR activation is crucial for host defense, 
excessive TLR signaling can lead to inflammatory and autoimmune disease (Kawai and 
Akira, 2010). TNFα is a potent proinflammatory cytokine produced following PAMP 
recognition by PRRs that is crucial for the clearance of certain pathogens including L. 
monocytogenes and M. tuberculosis but whose activity has also been linked to 
pathogenesis of inflammatory disease (Flynn et al., 1995; Pfeffer et al., 1993). How this 
balance between beneficial and detrimental effects of TNFα is determined represents a 
significant gap in our understanding of PRR signaling. Gaining an understanding of the 
signaling events that contribute to TNFα production and release is critical for identifying 
possible targets for directing the immune response downstream of PAMP recognition.  
 Syk is a protein tyrosine kinase that regulates many cellular processes, including 
B cell antigen receptor (immunoglobulin) and integrin signaling, inflammasome 
activation, phagocytosis, and reactive oxygen species production (Mocsai et al., 2010). 
Syk signaling is also important for cytokine release downstream of PAMP recognition; 
	  
	  
22	  
however, the mechanism by which Syk regulates this process is unresolved. Conflicting 
studies suggest that Syk acts downstream of receptors either to promote cytokine 
production (Chaudhary et al., 2007; Rogers et al., 2005; Sanjuan et al., 2006; Van Ziffle 
and Lowell, 2009) or to limit cytokine production (Hamerman et al., 2005; Han et al., 
2010; Zhang et al., 2009). The various approaches employed to study Syk may be 
contributing to the contradictory functions ascribed to this enzyme. Embryonic deletion of 
Syk results in perinatal lethality due to severe vascular abnormalities, hence mice with 
germline deletion of the gene cannot be used for analysis (Abtahian et al., 2003; Cheng 
et al., 1995; Turner et al., 1995). While use of radiation chimeras circumvents perinatal 
lethality, this produces developmental abnormalities including blocks in B cell maturation 
that may confound the interpretation of the effects of Syk deletion in innate immune 
cells. Other studies have relied on pharmacological inhibition of Syk which are likely 
complicated by off-target effects of these drugs (Geahlen and McLaughlin, 1989; Lin et 
al., 2010).  
Recognizing the limitations of these approaches, we have used complementary 
methodologies in primary cells and in a model cell line to resolve the role of Syk in 
signaling downstream of one critical PRR, TLR9, which responds to CpG DNA. Utilizing 
genetic deletion selectively in DCs and genetic knockdown in a macrophage cell line, we 
observed that Syk deficiency resulted in impaired CpG-induced exocytosis of TNFα, but 
not IL-6. Syk-deficient DCs and macrophages exhibited normal activation of canonical 
TLR9 signaling molecules and normal production of TNFα. Our data suggest a novel 
role for Syk downstream of PAMP signaling and provide insight into how particular 
cytokine responses are generated post-translationally.  
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Results 
 
Syk deficiency results in impaired secretion of CpG-induced TNFα. 
To determine how Syk affects cytokine response downstream of CpG signaling, we first 
treated RAW cells with the Syk inhibitor piceatannol. Syk-inhibited cells showed a near 
complete absence of secreted TNFα in response to CpG (Figure 2.1). Because of the 
potential off-target effects of pharmacological inhibition (Geahlen and McLaughlin, 1989; 
Lin et al., 2010), we decided to use a genetic approach to study Syk function. To study 
the role of Syk in DCs in vivo, we crossed mice expressing Cre recombinase under the 
control of the CD11c promoter to mice with loxP sites flanking Syk (Saijo et al., 2003), 
resulting in the conditional deletion of Syk in CD11c+ DCs (Syk flox). Western analysis 
of splenic DCs and bone marrow derived DCs (BMDCs) from Syk flox mice showed near 
complete deletion of Syk protein (Figure 2.2). To assess the role of Syk in cytokine 
response, Syk flox and control (Syk flox, Cre negative) mice were injected with CpG. 
Serum from CpG-injected Syk flox mice contained markedly less TNFα compared to that 
of control mice (Figure 2.3A), demonstrating an in vivo role for Syk in the regulation of 
CpG-induced TNFα.  
We next sought to investigate the contribution of CD11c+ cells to TNFα 
production and secretion. Culture supernatants from splenic DCs and BMDCs isolated 
from Syk flox mice contained a two-fold reduction in CpG-induced TNFα compared to 
supernatants from cells isolated from control mice (Figure 2.3B-C). We confirmed this 
phenotype using shRNA knockdown of Syk in the RAW macrophage cell line. Syk-
deficient RAW cells also showed a decreased level of TNFα in the supernatant following 
CpG stimulation compared to cells transduced with empty vector (control) (Figure 2.3D 
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and 2.4) or to RAW cells transduced with an irrelevant shRNA sequence that did not 
result in effective knockdown of Syk (Figure 2.4). Moreover, we found that Syk-deficient 
RAW cells and splenic DCs were impaired in their ability to secrete TNFα following 
stimulation with the TLR4 ligand LPS (Figure 2.5), demonstrating that Syk-dependent 
regulation of TNFα is not specific to TLR9. In contrast to the reduction in TNFα, Syk-
deficient splenic DCs and BMDCs secreted IL-6 and produced IFNβ normally in 
response to CpG (Figure 2.6A-C), indicating that Syk deficiency does not result in global 
dysfunction of the CpG signaling pathway. However, Syk knockdown resulted in 
decreased CpG-induced secretion of the chemokine monocyte chemotactic protein-1 
(MCP-1) (Figure 2.6D). Together, these data suggest that Syk selectively regulates 
TNFα and MCP-1, but not IL-6 or IFNβ, levels.  
 We speculated that Syk regulates CpG-induced TNFα levels by promoting its 
production or secretion, however it is possible that Syk regulates TNFα consumption or 
biological activity as has been seen in other cellular systems (Tartaglia and Goeddel, 
1992). To test the possibility that Syk deficiency might alter consumption of secreted 
TNFα, CpG-stimulated or unstimulated control and Syk-deficient RAW cells were 
exposed to a fixed amount of exogenous TNFα in the presence of a TNFα converting 
enzyme (TACE) inhibitor, which prevents cleavage and secretion of synthesized, 
endogenous TNFα into the supernatant. We measured no difference in TNFα levels in 
culture supernatants from cells replete or deficient in Syk (Figure 2.7), suggesting that 
the defect observed from Syk-deficient cells is not due to increased cellular consumption 
of secreted TNFα. 
Soluble TNF receptor cleaved from the cell surface can bind to soluble TNFα, 
thereby acting as a TNFα antagonist (Van Zee et al., 1992). To rule out the possibility 
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that Syk-deficiency promotes the production of soluble proteins binding secreted TNFα 
and, thus, preventing its detection by ELISA, we examined TNFα levels in supernatants 
that were boiled and denatured to disrupt protein-protein interactions, thus allowing for 
detection of all secreted TNFα.  Western analysis of denatured supernatants from CpG-
treated RAW cells revealed a decrease in secreted TNFα in the absence of Syk, arguing 
against selective production of an interfering TNFα binding protein in the context of Syk 
deficiency (Figure 2.7).  
 
Canonical signaling downstream of TLR9 is intact in the absence of Syk. 
Syk is known to be activated downstream of CpG stimulation (Lin et al., 2010; 
Sanjuan et al., 2006). To determine the role of canonical TLR9 signaling in Syk-
dependent regulation of TNFα, we investigated signaling events downstream of TLR9 in 
control and Syk-deficient RAW cells and BMDCs stimulated with CpG. Control and Syk-
deficient cells expressed similar levels of TLR9 (Figure 2.8A), and CpG-induced 
phosphorylation of the MAP kinases ERK and p38 occurred similarly in the presence 
and absence of Syk (Figure 2.8B). IκBα, a cytoplasmic protein whose interaction with 
NF-κB blocks its nuclear translocation, was similarly degraded after 30 minutes of CpG 
stimulation in control and Syk-deficient cells (Figure 2.8C), thus allowing nuclear 
translocation of NF-κB (Figure 2.8D). These data demonstrate that canonical signaling 
downstream of TLR9 is intact in the absence of Syk. 
MAP kinase and NF-κB activity can regulate TNFα transcription (Collart et al., 
1990; Dumitru et al., 2000; El Gazzar et al., 2007). Consistent with the observation that 
activation of these signaling intermediates was intact, TNFα mRNA levels were also 
similar in control and Syk-deficient cells following CpG stimulation (Figure 2.9A). 
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Moreover, Syk-deficient RAW cells, splenic DCs, and BMDCs produced TNFα protein 
similar to control cells following CpG stimulation in the presence of Brefeldin-A, which 
prevents exocytosis (Figure 2.9B). Taken together, these data demonstrate that in 
response to CpG, TNFα mRNA and protein generation occurs independently of Syk.  
 
TNFα  trafficking to the cell surface is impaired in the absence of Syk. 
We next considered whether Syk might be playing a role in the exocytosis and 
subsequent secretion of synthesized TNFα. To investigate this possibility, control and 
Syk-deficient RAW cells were stimulated with CpG, and membrane lysates were 
measured by Western analysis and by ELISA. Both measurements revealed elevated 
levels of TNFα protein in membranes of Syk-deficient cells compared to control cells 
(Figures 2.10A-B). Because the membrane preparations included intracellular and 
plasma membranes, this approach cannot distinguish TNFα retention in organelles 
within the cell from TNFα residing at the cell surface. It is known that prior to secretion, 
TNFα translated at the endoplasmic reticulum membrane traffics through the Golgi 
apparatus and the endosomal compartment before reaching the plasma membrane 
(Murray et al., 2005b; Stow et al., 2009). At the plasma membrane, membrane TNFα is 
cleaved by TACE, allowing soluble TNFα to be secreted from the cell (Black et al., 
1997). TNFα retention inside the cell would reflect a trafficking defect, while increased 
cytokine at the plasma membrane would suggest a defect in TACE activity. To 
distinguish between these possibilities, we assayed TACE activity in isolated membrane 
lysates and found no difference in TACE activity between the control and Syk-deficient 
cells, suggesting that both constitutive and CpG-induced TACE activity is intact in the 
absence of Syk (Figure 2.10C).  
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To investigate the role of Syk in TNFα trafficking to the plasma membrane, RAW 
cells and BMDCs were stimulated with CpG alone or with CpG in the presence of a 
TACE inhibitor (TAPI). TAPI allows TNFα to accumulate at the plasma membrane by 
blocking its cleavage and secretion, thus allowing us to measure trafficking of total TNFα 
to the cell surface, as reported previously (Low et al., 2010; Manderson et al., 2007). We 
observed similar amounts of surface TNFα on Syk-sufficient and Syk-deficient cells after 
CpG stimulation in the presence of TACE activity (Figure 2.10D, CpG alone). However, 
in the presence of TAPI, significantly less TNFα accumulated at the surface of the Syk-
deficient RAW cells and BMDCs compared to control cells (Figure 2.10D, CpG/TAPI). 
The decrease in surface TNFα in the absence of Syk was almost two-fold, consistent 
with the two-fold reduction in TNFα secretion (Figure 2.3) and the two-fold increase in 
TNFα membrane protein (Figures 2.10A-B). Taken together, these data demonstrate 
that Syk is important for trafficking of TNFα to the cell surface downstream of CpG 
signaling.  
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Discussion 
Here we demonstrate that in response to CpG, Syk is required for optimal trafficking of 
TNFα to the plasma membrane prior to secretion in macrophages and DCs. Mice 
harboring a DC-specific deletion of Syk showed a substantial reduction of serum TNFα 
levels following CpG injection. In vitro in cells lacking Syk, CpG stimulation resulted in 
activation of the canonical TLR9 signaling cascade resulting in normal increases in 
TNFα message and protein but diminished secretion of TNFα. Syk deficiency did not 
result in a global defect in cytokine secretion, however, as IL-6 secretion and IFNβ 
production were normal. Syk-deficient cells displayed significantly less TNFα at the cell 
surface compared to Syk-sufficient cells in response to CpG, consistent with the 
observation that total membrane TNFα levels were higher in the absence of Syk and that 
TACE activity was unaffected by Syk deletion. Together, these data suggest that Syk is 
important for trafficking of membrane-bound TNFα to the cell surface. Furthermore, the 
data demonstrate a novel mechanism for the differential secretion of cytokines 
downstream of CpG by way of Syk and suggest that CpG induces an active signal for 
cytokine secretion independent of production. 
 PRRs, including TLRs and Nod-like receptors, expressed by cells of the innate 
immune system can shape the immune response by bridging innate and adaptive 
immunity. Upon pathogen recognition, these receptors signal for the production of 
cytokines and for the upregulation of costimulatory molecules, both of which recruit and 
activate cells of the adaptive immune system. The type of cytokine released plays a key 
role in determining the appropriate effector cell response. TNFα is a potent pro-
inflammatory cytokine. While its signaling is important for clearance of certain 
pathogens, including L. monocytogenes and M. tuberculosis (Flynn et al., 1995; Pfeffer 
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et al., 1993), dysregulated TNFα production and signaling can lead to inflammatory 
disease (Flavell, 2002). Therefore, to maintain immune homeostasis, TNFα production 
and release must be tightly regulated. Indeed, TNFα transcription and translation are 
controlled by several factors (Collart et al., 1990; Dumitru et al., 2000; El Gazzar et al., 
2007; Han et al., 1990). Additionally, post-translational mechanisms of TNFα regulation 
have also been reported. Among these include cleavage of TNFα prior to secretion at 
the plasma membrane by TACE (Black et al., 1997) and regulation of its transport within 
the cell (Low et al., 2010; Murray et al., 2005a; Murray et al., 2005b; Stow et al., 2009). 
Here, we report a novel mechanism of TNFα regulation by way of exocytosis activated 
by PAMPs through the protein tyrosine kinase Syk in macrophages and DCs. This 
finding may have implications for additional immune cell types such as neutrophils, 
which were shown to have defective TNFα secretion in response to opsonized bacteria 
upon Syk deletion (Van Ziffle and Lowell, 2009). Similar to our data, these neutrophils 
generated TNFα protein normally, suggesting that Syk is also important for efficient 
exocytosis of TNFα downstream of PAMP signaling in this lineage. 
 IL-6 is a proinflammatory cytokine whose actions differ from that of TNFα. While 
both cytokines can recruit other cells of the immune system to the site of injury, such as 
monocytes, and promote inflammation, IL-6 can also influence the differentiation of T 
helper 17 cells (Ghoreschi et al., 2010; Veldhoen et al., 2006). Therefore, differential 
sorting and secretion of these cytokines is essential for tailoring the immune response to 
appropriately combat specific pathogens. Indeed, IL-6 and TNFα can segregate to 
different recycling endosome during exocytosis in macrophages, and these cytokines 
are delivered to different sites at the plasma membrane prior to secretion (Manderson et 
al., 2007; Murray et al., 2005a). We find that Syk-deficient cells secrete IL-6 normally in 
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response to CpG, which demonstrates that Syk is responsible for differential secretion of 
TNFα, perhaps at the level of endosomal sorting or plasma membrane sorting. Similarly, 
T cells also can differentially regulate cytokine secretion at the immunological synapse 
by polarizing certain cytokines at specific sites at the plasma membrane or by promoting 
more generalized secretion (Huse et al., 2006). Therefore, understanding the pathways 
involved in exocytosis of various cytokines and chemokines will provide insight into 
targeting specific effector molecules to treat inflammatory disease.  
 Our data demonstrate that Syk-deficient cells are defective in their ability to 
secrete MCP-1 in addition to TNFα in response to CpG. MCP-1 is a chemokine that can 
contribute to tissue injury through its recruitment of inflammatory cells, like monocytes, to 
the site of inflammation (Ajuebor et al., 1998). Similar to TNFα, MCP-1 has been 
implicated in inflammatory diseases including Rheumatoid arthritis and inflammatory 
bowel disease (Koch et al., 1992; Rantapaa-Dahlqvist et al., 2007; Spoettl et al., 2006). 
It is possible that these proteins are transported via a similar mechanism within immune 
cells involving Syk, but the trafficking intermediates involved in MCP-1 exocytosis are 
not clearly defined. Therefore, additional work is needed to determine the mechanism by 
which Syk affects MCP-1 secretion. Furthermore, it remains to be determined if Syk 
regulates IFNβ secretion, because our method of detection relied on its production via 
qPCR.  
 All TLRs signal through the transcription factor NF-κB which leads to 
transcription of a variety of cytokines and chemokines (Kawai and Akira, 2007). 
However, the release of such cytokines occurs differently upon stimulation of different 
receptors. For example, the amount of secreted TNFα varies upon TLR3, TLR4, or TLR9 
ligation (Dearman et al., 2009; El-Hage et al., 2011), even though these TLRs all 
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activate NF-κB similarly. Indeed, our data demonstrate normal NF-κB activation but 
defective TNFα secretion following CpG stimulation in the absence of Syk, while IL-6 
secretion was unaffected. Differential activation of trafficking molecules downstream of 
PAMP recognition may be a useful strategy for cells to affect the qualitative cytokine 
response of receptors and, therefore, tailor the immune response. Furthermore, an 
active signal distinct from that of NF-κB-induced transcription is critical for differentially 
sorting cytokines for appropriate release.  
 In summary, our data demonstrate that Syk is important for CpG-induced 
secretion of TNFα and MCP-1, but not IL-6, in DCs and macrophages. Differential 
sorting of proinflammatory cytokines and chemokines represents an important layer of 
regulation that can shape the immune response downstream of PAMP recognition. It will 
be important to determine other biochemical mediators involved in protein trafficking to 
uncover possible targets for therapeutic treatment of inflammatory disease. In the 
following chapter of this thesis, we will examine the biochemical mechanism by which 
Syk promotes CpG-induced TNFα exocytosis. 
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Figures 
 
 
 
 
 
 
 
 
 
Figure 2.1 Syk inhibition results in decreased CpG-induced TNFα  secretion in 
RAW cells. RAW cells were stimulated with CpG in the presence or absence of the Syk 
inhibitor piceatannol (pice) for 3 hours. TNFα was detected in the supernatants by 
ELISA. Graph is representative of at least 4 independent experiments performed in 
triplicate. Data were analyzed using an unpaired t test. *p<0.05  
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Figure 2.2 Syk is deleted in dendritic cells and RAW cells. DCs were isolated from 
the spleen or generated in vitro from the bone marrow of control and Syk flox CD11c Cre 
mice (top). RAW cells were transduced with lentivirus expressing Syk shRNA (bottom). 
Cells were lysed, and the presence of Syk protein was assessed by Western blot.  
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Figure 2.3 Syk deficiency results in less CpG-induced TNFα  secretion in vivo and 
in vitro. (A) Control (Syk flox Cre negative, n=4) and Syk flox (Syk flox CD11c Cre, n=5) 
mice were injected with PBS or 50µg CpG through the intraperitoneal cavity. One hour 
following injection, serum was collected from blood and analyzed for the presence of 
TNFα by ELISA. Control and Syk-deficient splenic DCs (B), BMDCs (C), and RAW cells 
(D) were stimulated with 10µg/ml CpG in vitro for 3 hours. Supernatants were analyzed 
for the presence of TNFα by ELISA. Control RAW were transduced with empty vector. 
Graphs are representative of at least 8 independent experiments for RAW cells, splenic 
DCs, and BMDCs performed in triplicate. Data were analyzed using an unpaired t test. 
*p<0.05 
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Figure 2.4 Syk knockdown results in decreased CpG-induced TNFα  in the 
supernatants. RAW cells were transduced with lentivirus expressing Syk shRNA. Cells 
were lysed, and the presence of Syk protein was assessed by Western blot (top). 
Transduced RAW cells were stimulated with CpG for 3 hours, and TNFα was detected in 
the supernatants by ELISA (bottom). Blots were developed on Odyssey and analyzed by 
Licor software. Bar graph is representative of at least 4 independent experiments 
performed in triplicate.   
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Figure 2.5 Syk deficiency results in less LPS-induced TNFα  secretion in vitro. 
Control and Syk-deficient splenic DCs (left) and RAW cells (right) were stimulated with 
100ng/ml LPS in vitro for 3 hours. Supernatants were analyzed for the presence of TNFα 
by ELISA. Graphs are representative of at least 2 independent experiments for each cell 
type performed in triplicate. Data were analyzed using an unpaired t test. *p<0.05 
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Figure 2.6 Syk deficiency results in differential CpG-induced cytokine responses. 
Control and Syk-deficient splenic DCs (A), BMDCs (B,C), and RAW cells (D) were 
stimulated with CpG in vitro for 3 hours. Supernatants were analyzed for the presence of 
IL-6 (A,B) and MCP-1 (D) by ELISA. (C) RNA was extracted from BMDCs stimulated 
with CpG. Quantitative RT-PCR was performed, and IFNβ message was normalized to 
GAPDH message. Bar graph is representative of 3 independent experiments performed 
in triplicate. ELISA graphs are representative of at least 3 independent experiments for 
RAW cells, splenic DCs, and BMDCs performed in triplicate. Data were analyzed using 
an unpaired t test. *p<0.05 
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Figure 2.7 Secreted TNFα  is not consumed or bound by soluble proteins 
abnormally in the absence of Syk. (A) CpG-stimulated RAW cells were treated with 
exogenous TNFα in the presence of TAPI to prevent secretion of endogenous, 
synthesized TNFα. Supernatants were harvested, and TNFα was detected by ELISA. 
Bar graph is representative of 3 independent experiments performed in triplicate. (B) 
TNFα was detected by Western blot from denatured supernatants of CpG-treated RAW 
cells. Quantification is expressed as a ratio of TNFα intensity of Syk-deficient cells to 
that of control cells over 3 independent experiments. Data were analyzed using a one 
sample t test against a theoretical mean of 1. *p<0.05 
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Figure 2.8 Canonical signaling downstream of TLR9 is intact in Syk-deficient cells. 
(A) RNA was extracted from RAW cells stimulated with CpG. Quantitative RT-PCR was 
performed, and TLR9 message was normalized to GAPDH message. Bar graph is 
representative of 3 independent experiments performed in triplicate. RAW cells were 
stimulated at various times with CpG, and cell lysates were analyzed by Western blot for 
phosphorylation of the MAP kinases ERK (B) and p38 (C) and degradation of IκBα (D). 
(E) Nuclear extracts were isolated from RAW cells stimulated for 30 minutes with CpG 
and analyzed by Western blot for nuclear translocation of NF-κB. Blots were developed 
on Odyssey and analyzed by Licor software and are representative of at least 4 
independent experiments.  
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Figure 2.9 CpG-induced TNFα  is 
transcribed and translated normally 
in Syk-deficient cells. (A) RAW cells 
were stimulated with CpG, and RNA 
was isolated and analyzed by 
quantitative RT-PCR. TNFα message 
was normalized to GAPDH message. 
Bar graph is representative of 3 
independent experiments performed in 
triplicate. (B) RAW cells were stimulated 
for 3 hours with CpG in the presence of 
Brefeldin A, and cells were harvested, 
permeabilized and stained for TNFα for 
analysis by flow cytometry. Histograms 
are representative of at least 5 
independent experiments performed for 
each cell type. 
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Figure 2.10 CpG-induced TNFα  trafficking is impaired in Syk-deficient cells. 
Membrane lysates were prepared from RAW cells stimulated for 1 hour with CpG and 
analyzed by ELISA (A) and by Western blot for TNFα (B). For quantification of Western 
blot, TNFα was normalized to MHC class II, and that ratio was compared between 
control and Syk-deficient cells over 6 independent experiments. A ratio of 1 would 
demonstrate equality between control and Syk-deficient cells. (C) TACE activity assay 
was performed with membrane lysates from untreated and CpG-stimulated RAW cells. 
Quantification is expressed as a ratio of TACE activity (measured by fluorescence) of 
Syk-deficient cells to control cells over 4 independent experiments. (D) BMDCs and 
RAW cells stimulated with CpG in the presence of TAPI were fixed and stained for TNFα 
for analysis by flow cytometry. Quantification is expressed as a ratio of surface TNFα 
median fluorescence intensity of Syk-deficient cells to that of control cells over 4 
independent experiments. Data were analyzed using a one sample t test against a 
theoretical mean of 1. *p<0.05 
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Chapter III 
Results 
Syk-dependent calcium signals mediate efficient CpG-induced exocytosis of TNFα   
in innate immune cells 
 
Introduction 
We previously demonstrated that Syk is important for trafficking of TNFα to the plasma 
membrane following CpG stimulation in macrophages and DCs. The signals 
downstream of Syk orchestrating cytokine exocytosis, however, are not known. 
Understanding the mediators involved in secretion of potent proinflammatory cytokines, 
like TNFα, is crucial for identifying potential targets for manipulating the immune 
response downstream of PAMP recognition.  
 Syk is involved in many cellular processes. Downstream of engagement of 
immunotyrosine-based activation motif (ITAM)-containing receptors, including the B cell 
receptor and Fc receptors, Syk becomes tyrosine phosphorylated and initiates a 
signaling cascade. Syk can associate with the adaptor molecule SH2 domain containing 
leukocyte protein of 65 kDa (SLP-65) (Kulathu et al., 2008), PI3 kinase (Moon et al., 
2005), and PLCγ (Law et al., 1996), downstream of which diverse signaling events 
occur, including activation of MAPKs, NF-κB, and calcium mobilization. Activation of 
these signaling intermediates leads to several cellular responses. Among them are 
cytokine release, proliferation, and survival. While Syk function has been elucidated 
downstream of these ITAM-bearing receptors (Mocsai et al., 2010), the mechanism by 
which Syk exerts its effects following PRR engagement to promote cytokine secretion is 
not clear.  
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 Calcium mobilization, a known downstream effector of Syk, has been implicated 
in synaptic vesicle transport and exocytosis in neurons (Pang and Sudhof, 2010).  
Therefore, we sought to determine if calcium signaling downstream of Syk is important 
for CpG-induced TNFα secretion. Indeed, our data demonstrate that Syk orchestrates a 
calcium-dependent signaling event leading to the activation of calcium calmodulin kinase 
II (CaMKII). This process facilitates the efficient exocytosis of TNFα downstream of CpG 
signaling.  
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Results 
Calcium signaling is impaired in the absence of Syk in response to CpG. 
Known downstream effectors of Syk include PLCγ (Law et al., 1996) and cytosolic 
calcium (Kulathu et al., 2008; McVicar et al., 1998), and calcium signaling has been 
implicated in synaptic vesicle trafficking and exocytosis in neurons (Pang and Sudhof, 
2010). We, therefore, sought to determine whether Syk dependent mobilization of 
intracellular calcium regulates TNFα secretion and accounts for the defect observed in 
Syk-deficient cells. Control RAW cells exhibited a rise in intracellular calcium levels in 
response to CpG in the presence of extracellular calcium (Figure 3.1A, 8 minutes). In 
contrast, Syk-deficient RAW cells failed to mobilize calcium upon CpG stimulation under 
these same conditions. This defect in calcium was selective, however, as cells lacking 
Syk were able to mobilize calcium in response to ATP, a ligand for G-protein coupled 
purinergic receptors that results in Syk-independent calcium flux (Surprenant and North, 
2009), and to pharmacological release of calcium from internal stores with ionomycin. 
These data demonstrate that CpG-induced calcium mobilization is defective in the 
absence of Syk.  
To test whether the increase in intracellular calcium we observed following CpG 
stimulation was important for TNFα secretion, we treated RAW cells with BAPTA-AM, an 
intracellular calcium chelator. Stimulation of BAPTA-treated cells with CpG failed to elicit 
secretion of TNFα (Figure 3.1B), suggesting that the Syk-dependent calcium response 
regulates TNFα secretion. To test this further, we designed a gain of function experiment 
reasoning that pharmacological mobilization of calcium should rescue the TNFα 
secretion defect in the Syk-deficient cells. Indeed, addition of ionomycin and CpG 
increased the total amount of TNFα secreted into the supernatants from the Syk-
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deficient RAW cells to control levels (Figure 3.1C), suggesting that calcium signaling is 
important for efficient TNFα regulation and that Syk is mediating this process. The same 
was true for MCP-1 levels (Figure 3.1D). These results indicate that CpG mediated Syk-
dependent calcium signals regulate efficient trafficking of TNFα to the plasma membrane 
for its secretion from the cell and regulate MCP-1 secretion.  
 
PLCγ2 knockdown results in defective CpG-induced TNFα  secretion. 
PLCγ2 is a known target of Syk kinase activity, and its activation results in 
calcium release from the endoplasmic reticulum. We, therefore, reasoned that 
suppression of PLCγ2 should result in a similar phenotype as suppression of Syk. To 
test this hypothesis, we gene silenced PLCγ2 using shRNA in RAW cells and found that 
PLCγ2-deficient cells phenocopied Syk-deficient cells; TNFα protein was produced 
normally, but its secretion was impaired with a similar magnitude as Syk deficiency 
following CpG stimulation (Figure 3.2). Moreover, TNFα secretion was rescued upon 
addition of ionomycin. These data are consistent with PLCγ2 acting as the downstream 
effector of Syk and being required for the optimal calcium-induced exocytosis of TNFα.  
 
CaMKII promotes CpG-induced exocytosis of TNFα  downstream of Syk. 
We next sought to identify the target of calcium that regulates TNFα secretion in 
macrophages and DCs. We focused on CaMKII, a serine threonine protein kinase 
whose phosphorylation has been reported following TLR stimulation (Liu et al., 2008). 
Binding of CaMKII to calcium induces a structural rearrangement resulting in its 
autophosphorylation (Griffith, 2004), a necessary step for activation of its downstream 
targets. In neurons, CaMKII has been reported to participate in the phosphorylation of 
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molecules involved in exocytosis (Hilfiker et al., 1999; Verona et al., 2000). Consistent 
with CaMKII being the target of CpG-induced Syk and PLCγ2 dependent calcium 
signaling, we found that Syk-deficient BMDCs exhibited defective CpG-induced CaMKII 
phosphorylation (Figure 3.3A). We next looked more directly at the role of CaMKII in 
TNFα secretion by suppressing its expression in RAW cells. We found that CaMKII-
deficient cells, like those lacking Syk or PLCγ2, generated normal amounts of TNFα 
protein but secreted less cytokine in response to CpG (Figure 3.3 B-C). This secretion 
defect was not rescued by ionomycin, which is consistent with the notion that CaMKII is 
downstream of calcium mobilization. Thus, we have identified Syk-PLCγ2 dependent 
activation of calcium-induced CaMKII signaling as a novel pathway for the regulation of 
TNFα secretion (Figure 3.4). This suggests that in addition to activating the transcription 
and translation of cytokines, CpG provides an active signal to promote the trafficking and 
secretion of TNFα. 
	  
	  
47	  
Discussion 
In the second chapter of this thesis, we identified a role for Syk in trafficking and 
exocytosis of TNFα, but not IL-6, downstream of CpG signaling. Here we demonstrate 
that the signals required for this process downstream of Syk rely on calcium mobilization 
and subsequent CaMKII phosphorylation. Once activated, the Syk binding partner PLCγ 
cleaves PIP2 into diacylglycerol and IP3. IP3 in turn binds to its receptors located on the 
endoplasmic reticulum membrane, and these receptors serve as calcium channels and 
thus allow an influx of calcium from ER stores. PLCγ2-deficient DCs cannot mobilize 
calcium in response to the TLR4 ligand LPS (Zanoni et al., 2009) providing a precedent 
for activation of this pathway by TLR ligands. We found that knockdown of PLCγ2 
resulted in decreased CpG-induced TNFα secretion, which was rescued by ionomycin. 
Knockdown of the calcium-responsive kinase CaMKII also resulted in decreased CpG-
induced TNFα secretion. Similarly, Syk-deficient cells showed defective CpG-induced 
calcium mobilization and CaMKII phosphorylation. These data demonstrate that a Syk-
dependent pathway signaling through a PLCγ-calcium-CaMKII axis is responsible for 
optimal TNFα secretion downstream of CpG activation.  
Calcium signaling is a well-established pathway for exocytosis, particularly for the 
transport of synaptic vesicles in neurons (Pang and Sudhof, 2010). For example, 
intracellular membrane fusion events necessary for cytokine secretion involve the 
assembly of Soluble NSF Attachment Protein Receptors (SNAREs), the activation of 
which has been linked to calcium mobilization. CaMKII was reported to phosphorylate 
proteins important for exocytosis in neurons, including the SNARE-interacting molecule 
Synaptotagmin, which initiates membrane fusion events (Hilfiker et al., 1999; Verona et 
al., 2000). In macrophages, SNAREs including VAMP3, Syntaxin6, and Vti1B were 
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upregulated following LPS stimulation, and VAMP3 colocalized with TNFα in recycling 
endosomes (Murray et al., 2005a; Murray et al., 2005b). It is plausible, therefore, that 
Syk is orchestrating a calcium-dependent signaling event that triggers exocytosis by way 
of Synaptotogamin and SNARE activation downstream of CpG stimulation. IL-6 
trafficking and exocytosis were also reported to be dependent on the SNARE machinery, 
but it is possible that IL-6 relies on a different set of CaMKII-independent trafficking 
intermediates for its secretion. Therefore, in addition to signaling for activation of NF-κB 
and cytokine transcription, CpG must also provide distinct signals for activation of 
trafficking machinery to ensure exocytosis and secretion of cytokines. This provides a 
useful way for tightly coordinating the differential secretion of potent proinflammatory 
cytokines in order to adequately direct the effector cell response. Furthermore, because 
similar trafficking intermediates are employed for cytokine release downstream of PRRs 
in innate immune cells and for synaptic vesicle exocytosis in neuronal cells (Jahn and 
Fasshauer, 2012), understanding the signaling pathways that regulate these processes 
have broad implications for release of cellular contents in different tissues throughout the 
body. 
In summary, we have demonstrated a novel pathway involving a PLCγ2-calcium-
CaMKII axis downstream of Syk important for the exocytosis of TNFα, but not IL-6, 
following CpG stimulation. These findings establish Syk as an important signaling 
intermediate for the differential release of cytokines downstream of PAMP recognition to 
elicit an appropriate cytokine response. The regulation of exocytosis by PAMPs marks a 
new area to explore in the control of cytokine release by PRRs. There likely exist other 
biochemical mediators activated by PRRs that regulate the secretion of cytokines other 
than TNFα. Understanding in which vesicular compartments these cytokines reside and 
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which pathways regulate their secretion will provide greater insight into how particular 
cytokine responses are generated.  
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Figures 
 
 
Figure 3.1 Calcium signaling is important for TNFα  secretion downstream of Syk. 
(A) RAW cells were loaded with the calcium sensitive dye Fura-2, and calcium 
mobilization was detected in response to CpG, ATP, and ionomycin. Plots are 
representative of 5 independent experiments. RAW cells were stimulated with CpG and 
BAPTA (B) and with CpG and ionomycin (C-D) for 3 hours. Culture supernatants were 
analyzed by ELISA for TNFα (B-C) and MCP-1 (D). Bar graphs are representative of at 
least 3 independent experiments performed in triplicate. *p<0.05 
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Figure 3.2 PLCγ2 deficiency results in impaired CpG-induced TNFα  secretion. (A) 
RAW cells transduced with PLCγ2 shRNA delete PLCγ2 protein (Western blot). PLCγ2 
control cells were transduced with an irrelevant shRNA sequence. PLCγ2-deficient RAW 
cells were stimulated with CpG or with CpG and ionomycin for TNFα detection by 
ELISA. (B) PLCγ2-deficient RAW cells were stimulated with CpG in the presence of 
Brefeldin A for detection of intracellular TNFα by flow cytometry. ELISA data are 
representative of 4 independent experiments performed in triplicate. Fold induction of 
intracellular TNFα with CpG was calculated based on median fluorescence intensity. Bar 
graph (B, right panel) represents summary data from 3 independent experiments, +/- 
SEM.  *p<0.05 
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Figure 3.3 CaMKII is 
important for CpG-
induced TNFα  secretion 
downstream of Syk. (A) 
BMDCs were stimulated 
with CpG or ionomycin at 
various times, and lysates 
were harvested and 
analyzed by Western blot 
for phospho-CaMKII.  (B) 
For quantification, pCamKII 
was normalized to total 
ERK, and that ratio, at 
each time of stimulation, 
was compared to the signal 
at baseline (left panel). 
Normalized pCamKII from 
CpG-stimulated cells was 
also compared to the 
maximum signal achieved 
with ionomycin stimulation 
(right panel). Blot is 
representative of 3 
independent experiments. 
(C) RAW cells transduced 
with CaMKII shRNA delete 
CaMKII protein (Western 
blot). CaMKII control cells 
were transduced with an 
irrelevant shRNA 
sequence. (D) CaMKII-
deficient RAW cells were 
stimulated with CpG or with 
CpG and ionomycin for 
TNFα detection by ELISA. (E) RAW cells were stimulated with CpG in the presence of 
Brefeldin A for detection of intracellular TNFα by flow cytometry. (F) Fold induction of 
intracellular TNFα with CpG was calculated based on median fluorescence intensity. 
ELISA data are representative of 4 independent experiments performed in triplicate. Bar 
graph represents summary data from 3 independent experiments, +/- SEM.  *p<0.05 
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Figure 3.4 Syk dependent calcium signals mediate efficient CpG-induced 
exocytosis of TNFα . Upon CpG stimulation, the canonical TLR9 machinery activates 
NF-κB, resulting in Syk-independent transcription of proinflammatory cytokines like IL-6 
and TNFα. These cytokines are packaged into secretory vesicles after synthesis. CpG 
also activates a Syk-dependent signaling cascade resulting in calcium release through 
PLCγ2. Calcium binds to CaMKII, leading to its autophosphorylation, a step necessary 
for activation of its downstream targets. This signaling pathway is important for the 
trafficking of intracellular TNFα, but not IL-6, to the plasma membrane. Thus, Syk 
activation downstream of CpG stimulation results in differential trafficking of cytokines.  
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Chapter IV 
Results 
TLR9 tyrosine 870 mediates efficient receptor maturation 
 
Introduction 
The pattern recognition receptor TLR9 binds CpG DNA from pathogenic stimuli such as 
viruses and bacteria in the endosomal compartment. Upon ligand recognition, the 
receptor can recruit MyD88 to initiate signaling for the induction of NF-κB-dependent 
transcription of proinflammatory cytokines and interferon regulatory factor (IRF)-
dependent transcription of type I IFNs. Together, these cytokines contribute to the 
immune response by recruiting and activating other cells of the immune system to aid in 
pathogen clearance. 
 Prior to ligand recognition, a functional receptor must be generated to initiate 
signaling. From the endoplasmic reticulum, TLR9 is escorted to the endosome by its 
physical interaction with the membrane protein UNC93B1 (Brinkmann et al., 2007; Kim 
et al., 2008). In the absence of UNC93B1 TLR9 fails to traffic to the endosome, and 
CpG-induced signaling is abolished. Once in the endosome, the receptor is 
proteolytically processed to generate its mature form (Park et al., 2008). While the 
unprocessed receptor is capable of binding CpG, only the processed form can interact 
with MyD88 to initiate downstream signaling. This ensures that inappropriate signaling is 
prevented.  
 All TLRs contain a relatively conserved TIR domain that facilitates interactions 
with other TLRs and other TIR domain-containing proteins, including the adaptor 
molecules Trif and MyD88 (Jiang et al., 2006; Li et al., 2005; Ohnishi et al., 2009). This 
domain is comprised of about 160 amino acids and is located in the cytoplasmic portion 
	  
	  
55	  
and is essential for downstream signaling. The domain contains three different short 
conserved regions, termed box 1 (F/Y)DA, box 2 RDXXPG, and box 3 FW, all of which 
were reported to be important for receptor function based on a series of alanine 
mutations (Slack et al., 2000). Interestingly, the tyrosine residue of box 1 is conserved 
among all TLRs except, TLRs 1, 6, and 12. These receptors instead contain a 
phenylalanine in that position. Moreover, these are the only TLRs that do not 
homodimerize. TLRs 1 and 6 heterodimerize with TLR2, and TLR12 forms heterodimers 
with TLR11. Thus, these observations raise the question of whether tyrosine 
phosphorylation of that residue is important for full receptor activation or perhaps 
whether there exists a structural requirement at that position for activation. To 
investigate these possibilities, we generated TLR9 mutants containing either 
phenylalanine or alanine at residue 870. Although preliminary, we observed defective 
receptor maturation with both mutations. The alanine mutation completely abolished 
receptor activation, while the phenylalanine mutation partially diminished TLR9 
maturation. These data suggest that perhaps there are both phosphorylation and 
structural requirements at residue 870, but additional experiments are needed to 
determine the mechanism by which tyrosine 870 affects TLR9 maturation.   
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Results 
Mutation of TLR9 tyrosine 870 results in decreased receptor maturation. 
To investigate the effects of tyrosine 870 on CpG-induced TLR9 signaling, we generated 
retrovirus expressing either WT HA-tagged TLR9, HA-tagged receptor in which tyrosine 
870 has been mutated to phenylalanine (Y870F), or HA-tagged receptor in which 
tyrosine 870 has been mutated to alanine (Y870A). Transcription of HA-tagged TLR9 is 
followed by an internal ribosomal entry site leading to expression of green fluorescent 
protein (GFP). WT TLR9, based on HA expression, was expressed in TLR9 deficient 
BMDCs and rescued cytokine secretion following CpG stimulation (Figure 4.1). The full-
length glycoysylated TLR9 is proteolytically processed to generate a mature, functional 
receptor (Park et al., 2008). We observed expression of both the unprocessed (160 
kilodaltons) and processed (80 kilodaltons) receptor in TLR9 deficient bone marrow 
transduced with WT TLR9 (Figure 4.1). BMDCs also expressed the full-length receptor 
when transduced with either TLR9 Y870F or Y870A (Figure 4.2A-B). However, the 
Y870A-expressing cells did not generate the mature form of TLR9, and the Y870F-
expressing cells demonstrated reduced expression of processed receptor. Furthermore, 
we observed similar transduction efficiency of each construct, based on GFP 
expression, but diminished HA expression when 870 was mutated to F or A (Figure 
4.2C-D). Collectively, these data suggest that tyrosine 870 is important for receptor 
maturation.  
Because tyrosine 870 is located in the TIR domain, we next considered whether 
this residue is also important for TLR9 signaling. CpG stimulation of TLR9 KO cells 
expressing the Y870F mutant demonstrated impaired secretion of TNFα and IL-6 (Figure 
4.3A). However, when we normalized the amount of CpG-induced cytokine in the 
supernatant to the expression of the processed form of the receptor, we observed 
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comparable levels of TNFα and IL-6 between WT TLR9-expressing cells and Y870F-
expressing cells (Figure 4.3B). Moreover, HA+ cells produced similar amounts of CpG-
induced cytokine whether WT TLR9 or Y870F was stimulated (Figure 4.3C), indicating 
that the processed form of the receptor is functional when there is a phenylalanine 
present at the 870 position. Together, these data suggest that tyrosine 870 is important 
for TLR9 maturation but dispensable for CpG-induced signaling.  
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Discussion 
Although preliminary, our data suggest that a tyrosine at position 870 is important for 
receptor maturation of TLR9. The Y870A mutation abolished TLR9 maturation, and 
transduction with the Y870F mutant resulted in diminished expression of the processed 
form. However, the remaining mature Y870F receptor was able to signal appropriately 
upon CpG stimulation. This indicates that once processed, mature TLR9 does not rely 
upon tyrosine 870 for ligand recognition and downstream signaling. 
 TLR9 binds UNC93B1 in the endoplasmic reticulum for its transportation to the 
endosomal compartment (Brinkmann et al., 2007; Kim et al., 2008). Once in the 
endosome, the receptor is cleaved to generate functional TLR9 that can interact with 
MyD88 and initiate downstream signaling (Park et al., 2008). It is unclear from our data if 
the receptor mutated at residue 870 is impaired in its ability to bind UNC93B1 and is, 
therefore, not trafficking to the endosome, or whether TLR9 is present in the endosome 
but unable to be processed into the functional form. The predicted cleavage site for 
TLR9 is between amino acids 441 and 470, a site flanked by two leucine rich repeat 
domains (Park et al., 2008). Therefore, it is unlikely that residue 870 is involved in 
receptor cleavage, but it is possible that the Y870A mutant is misfolded such that the 
cleavage site is no longer accessible to proteases. It was reported that amino acids 812 
and 813, located between the transmembrane domain and box 1 of the TIR domain, 
were important for UNC93B1 binding (Kim et al., 2013). Because of the proximity of this 
region to tyrosine 870, it is possible that the structure of the mutants has changed 
sufficiently to affect UNC93B1 binding and subsequent transport of TLR9 out of the 
endoplasmic reticulum to the endosome. We are pursuing studies investigating the 
localization of TLR9 Y870F and Y870A. If tyrosine 870 is important for receptor 
trafficking, it is likely that the Y870A mutant and to a lesser extent, the Y870F mutant, 
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will be stuck in the endoplasmic reticulum and absent from the endosome. For these 
studies, we can take advantage of the glycosylation pattern of TLR9. Furthermore, 
investigating localization of GFP-tagged receptor will be useful for determining how 
tyrosine 870 affects TLR9 trafficking.  
 Because the Y870F receptor results in a phenotype different from that of the 
Y870A receptor, it is possible that phosphorylation of that residue is important for TLR9 
activation. Studies are underway to determine the phosphorylation status of tyrosine 
870. The Y870F mutant demonstrated only a partial defect in the ability of TLR9 to 
mature, so perhaps phosphorylation of a different tyrosine residue is sufficient to allow 
limited receptor activation. Tyrosine kinase inhibition could be a useful strategy to 
determine whether tyrosine phosphorylation is necessary for generation of a functional 
receptor, but to answer the question more definitively, a mass spectrometry approach is 
necessary to determine if tyrosine 870 is phosphorylated. 
 In summary, our data suggest that the conserved tyrosine residue located in box 
1 of the TIR domain is important for TLR9 activation. The mechanism, phosphorylation 
and/or structural requirements, by which this residue exerts its effects is currently 
unknown. It will be interesting to investigate how this residue affects trafficking and 
localization of the other TLRs. Additionally, it is possible that the tyrosine of TIR box 1 is 
important for receptor dimerization. Most TLRs homodimerize. TLR1 and TLR6 form 
dimmers with TLR2, and TLR11 heterodimerizes with TLR12, suggesting that perhaps 
the presence of a tyrosine at position 870 allows for efficient receptor dimerization. 
Additional work is needed to investigate how the conserved tyrosine of TIR domain box 
1 influences receptor activation. 
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Figures 
 
Figure 4.1 WT TLR9 is expressed and rescues signaling in TLR9 deficient BMDCs. 
TLR9 KO bone marrow was transduced with MigR retrovirus expressing HA-tagged WT 
TLR9. (A) Western blot analysis of whole cell lysates demonstrated expression of WT 
TLR9 in TLR9-deficient BMDCs. (B) BMDCs were stimulated for 3 hours with CpG 
(1µg/ml). Supernatants were harvested, and TNFα was detected by ELISA.  
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Figure 4.2 Decreased expression of mature receptor when Tyr870 is mutated. (A) 
Cells were lysed, and the presence of TLR9 was assessed by blotting with HA. (B) 
Expression of the unprocessed form of TLR9 (160kD) was normalized to Total Erk, and 
the expression of processed receptor (80kD) was normalized to the resulting ratio. Blots 
were developed on Odyssey and analyzed by Licor software.  (C-D) BMDCs were 
harvested and stained with antibodies for CD11c and HA. (C) GFP expression was 
determined for live, CD11c+ cells by flow cytometry. (D) HA expression was determined 
for GFP+CD11c+ cells by flow cytometry.  
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Figure 4.3 TLR9 Y870F signals appropriately for cytokine secretion and 
production. (A) TLR9 KO BMDCs expressing WT TLR9, Y870F, or Y870A were 
stimulated for 3 hours with CpG (1µg/ml). Supernatants were harvested, and TNFα and 
IL-6 were measured by ELISA. (B) TNFα and IL-6 levels from B were normalized to the 
active (80kD) receptor, as shown in Figure 4.2. (C) CpG-induced intracellular levels of 
TNFα and IL-6 were determined for HA+GFP+CD11c+ cells by flow cytometry. 
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Chapter V 
 
Discussion and future directions 
  
In this thesis, we examined the role of tyrosine phosphorylation in signaling 
downstream of TLRs. We first investigated the function of the protein tyrosine kinase Syk 
using genetic knockdown in macrophages in vitro and DC-specific genetic deletion in 
vivo. We uncovered a novel role for Syk in the promotion of TNFα and MCP-1 
exocytosis in response to CpG in DCs and macrophages. We extended these studies by 
investigating the mechanism by which Syk exerts its function of TNFα regulation and 
found that Syk-dependent calcium mobilization activates CaMKII, which promotes TNFα 
exocytosis. It will be important to investigate where along the trafficking pathway CaMKII 
mediates TNFα exocytosis and whether a similar pathway exists for MCP-1. Shifting 
focus from downstream signaling events, we focused on the receptor itself as a mediator 
of CpG-induced signaling. TLRs contain a relatively conserved cytoplasmic TIR domain 
harboring a tyrosine in the box 1 region. Preliminary results with mutational analysis 
suggest that this tyrosine is important for receptor maturation but dispensable for 
downstream signaling. It is still unknown whether tyrosine phosphorylation is the 
mechanism mediating TLR9 maturation, and future experimentation will address this 
hypothesis. The data presented in this thesis generate interesting questions to explore 
for future investigations.  
 
Syk-dependent “secretome” 
 Our data demonstrate that in response to TLR9 stimulation, Syk-deficient 
macrophages and DCs are impaired in their ability to secrete TNFα and MCP-1, while 
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IL-6 secretion is intact. Syk-deficient cells also demonstrate defective TNFα secretion 
downstream of TLR4 stimulation, suggesting the possibility that Syk-dependent 
regulation of cytokines is not specific to one receptor. This was a very unexpected 
finding, because tyrosine kinases have been described in other cellular systems as 
regulators of proximal signaling events ultimately affecting gene expression. For 
example, downstream of B cell receptor ligation, Syk is recruited to the phosphorylated 
ITAMs present in the receptor. This recruitment leads to activation of downstream 
effectors SLP-65, PLCγ, and MAPKs, ultimately leading to an increase in BCR-induced 
transcription. However, our data suggest that TLR9-induced activation of MAPKs and 
NF-κB and TNFα production is normal in the absence of Syk. Rather, Syk is functioning 
outside of the canonical TLR9 signaling machinery to promote TNFα secretion. These 
data demonstrate a previously underappreciated role for Syk specifically for TNFα 
trafficking in response to a non-ITAM bearing receptor, and they expand upon the results 
reported from Cliff Lowell’s group. Lowell showed that Syk-deficient neutrophils had 
reduced TNFα secretion, but intact message, in response to opsonized bacteria (Van 
Ziffle and Lowell, 2009). Our data point the defect specifically to trafficking, and we 
include a biochemical mechanism that contributes to this process. Our findings also 
have implications for cytokine sorting. Jennifer Stow’s group reported that IL-6 and TNFα 
can be sorted into different vesicles at the Golgi complex (Manderson et al., 2007). It is 
possible that Syk-dependent signals participate in the differential sorting of these 
cytokines at the Golgi complex, because we observe defective TNFα but normal IL-6 
secretion in the absence of Syk. It will be useful to investigate the localization of TNFα in 
the Syk-deficient cells to confirm that the unsecreted cytokine is stuck at the trans-Golgi 
network. Furthermore, our data suggest that CpG must provide an additional signal 
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distinct from canonical activation of TLR9-induced cytokine transcription to initiate the 
activation of cytokine exocytosis and release.  
Additional work is needed to determine the extent to which Syk deficiency affects 
cytokine responses globally. We are currently investigating Syk-dependent secretion in 
response to various stimuli, including ligands for TLR2/6, TLR3, TLR5, TLR7, and TLR8. 
We anticipate defective TNFα and MCP-1 secretion in the absence of Syk in response to 
these stimuli, which would suggest that Syk activity is not limited to just TLRs 4 and 9. 
Therefore, Syk could be a potential target for therapeutic intervention during infections 
and inflammatory diseases for which several PRRs are activated. Furthermore, we are 
investigating the secretion of a wide array of inflammatory mediators downstream of 
these receptors to determine the existence of a Syk-dependent “secretome.” It is 
possible that there are cytokines whose secretion is more affected by Syk deletion than 
TNFα (as we saw with MCP-1), and there are likely cytokines whose secretion is 
completely Syk-independent (as we observed with IL-6). More work is needed to 
determine the mechanism by which Syk affects MCP-1 exocytosis. It is possible that 
MCP-1 traffics in a manner similar to TNFα and that Syk regulates a shared mediator of 
cytokine trafficking. Therefore, it will be important to determine the cytokines affected by 
Syk deletion and how these cytokines traffic in response to PRR engagement. Moreover, 
because we find that Syk deletion results in a two-fold decrease in TNFα secretion, we 
speculate that Syk can modulate different “pools” of cytokines. Perhaps there exists a 
Syk-independent pool of TNFα that relies on a different set of trafficking molecules. This 
level of regulation can be advantageous for a cell trying to secrete a fixed amount of 
cytokine in response to an insult. Cells can qualitatively determine the cytokine response 
by either engaging or not engaging Syk. Furthermore, modulating Syk activity might 
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represent a way to selectively diminish cytokine responses without abolishing the entire 
TLR pathway. It is also possible that different cell types utilize Syk for all existing TNFα 
pools or perhaps for no TNFα pools. Syk-deficient neutrophils displayed almost a 75% 
reduction in TNFα release in response to opsonized bacteria (Van Ziffle and Lowell, 
2009), suggesting that Syk regulates the majority of TNFα in this lineage. Utilizing 
lineage-specific deletion of Syk in vivo will be important for determining the extent to 
which different cell types utilize Syk for cytokine secretion following PRR engagement. 
 All TLRs signal through the transcription factor NF-κB which leads to 
transcription of a variety of cytokines and chemokines (Kawai and Akira, 2007). 
However, the release of such cytokines occurs differently upon stimulation of different 
receptors. For example, the amount of secreted TNFα varies upon TLR3, TLR4, or TLR9 
ligation (Dearman et al., 2009; El-Hage et al., 2011), even though these TLRs all 
activate NF-κB similarly. Indeed, our data demonstrate normal NF-κB activation but 
defective TNFα secretion following CpG stimulation in the absence of Syk, while IL-6 
secretion was unaffected. Differential activation of Syk and/or trafficking molecules 
downstream of PAMP recognition may be a useful strategy for cells to affect the 
qualitative cytokine response of receptors and, therefore, tailor the immune response by 
regulating exocytosis. Furthermore, an active signal distinct from that of NF-κB-induced 
transcription is critical for differentially sorting cytokines for appropriate release.  
Based on the pathogenic stimulus, a cell can determine the amount of cytokine, 
like TNFα, to release by either engaging Syk or not engaging Syk following receptor 
ligation. Because different cytokines exert different effects on the immune system, this 
strategy allows for appropriate release of cytokines to achieve the desired response. For 
example, TNFα and IL-6 both promote inflammation in response to PRR engagement, 
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but IL-6 can additionally facilitate differentiation of T cells into the T helper 17 lineage 
(Ghoreschi et al., 2010; Veldhoen et al., 2006). Therefore, following infection with 
Listeria monocytogenes, an intracellular pathogen for which a T helper 17 cell response 
is not useful, it is likely more advantageous for responding cells like macrophages to 
engage Syk following PRR engagement to induce maximal TNFα release. In response 
to a fungal infection, the PRRs might not need to engage Syk, thus allowing for reduced 
TNFα release. The limited TNFα release might be a strategy for the immune system to 
promote inflammation for pathogen clearance but to limit the amount of cytokine that 
could damage host tissues. Once a Syk-dependent “secretome” has been identified, it 
will be important to challenge mice harboring lineage-specific deletions of Syk with 
various pathogens to understand how Syk deletion affects the immune response.  
 
Constitutive versus regulated exocytosis of CpG-induced TNFα  
 The literature on cytokine exocytosis defines cytokines secretion by regulated or 
constitutive exocytosis. During regulated exocytosis, cytokines packaged into vesicles in 
a resting cell are rapidly released upon some stimulus. During constitutive exocytosis, a 
stimulus signals for de novo synthesis of cytokines, and these cytokines are then 
immediately packaged and shuttled out of the cell. However, exocytosis of molecules 
other than cytokines, including hormones and membrane components, is described 
differently (Arvan and Halban, 2004). For example, constitutive exocytosis of insulin 
refers to the rapid movement of proteins packaged in small vesicles budding from the 
trans-Golgi network for spontaneous discharge. Conversely, the regulated secretory 
pathway involves packaging of cargo proteins in vesicles distinct from the small 
secretory vesicles involved in the constitutive pathway. The cargo is then delivery to 
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granules in a highly regulated fashion for subsequent release. The distinction between 
these two pathways for cytokine secretion is the presence or absence of de novo 
cytokine transcription; conversely, the distinction for non-cytokine cargo is the type of 
vesicle and the presence or absence of regulatory proteins. While our data suggest that 
Syk differentially regulates cytokine exocytosis, the description of the secretory 
pathways of non-cytokine cargo can offer an explanation for the Syk-dependent and the 
Syk-independent secretion of TNFα. That is, Syk regulates the vesicular movement of 
TNFα independent of its transcription.  
 Insulin release from pancreatic beta cells has been described as the result of a 
biphasic secretion pattern (Hou et al., 2009). The constitutive secretion of a rapidly 
released pool of hormone provides for a strong burst of insulin release upon some 
stimulus. The reserved pool can be released at a later time contributing to the second 
wave of insulin secretion. The immune response might benefit from a biphasic release of 
TNFα. A strong discharge of TNFα early in the immune response would promote the 
recruitment of additional immune effector cells and would participate in control of 
pathogen clearance. Because this cytokine also imposes harmful damage to host cells 
(see discussion below), it would be beneficial for the host to turn off the initial strong 
burst of TNFα release and, instead, allow a slow, constitutive secretion to combat 
lingering pathogen. By engaging Syk in response to microbial insults, the immune 
system can regulate this strong release of cytokine to disrupt pathogen replication. 
Turning Syk off would allow cells to secrete less TNFα once the “workload” of the 
immune system decreases. We measured TNFα secretion from one to five hours of CpG 
stimulation and observed a fifty percent reduction in cytokine levels in that time frame in 
the absence of Syk. It’s possible that later during the response, the secreted TNFα 
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levels would be similar between control and Syk-deficient cells. It will be useful to 
perform a kinetic study on TNFα secretion in the response to CpG in the presence and 
absence of Syk. 
 Additionally, it will be interesting to investigate the Syk-independent and the Syk-
dependent pools of TNFα in our cells. Peter Arvan described clathrin-coated vesicles for 
the delivery of insulin to the plasma membrane during regulated exocytosis (Arvan and 
Halban, 2004). Conversely, the small percentage of insulin secreted constitutively is 
packaged into secretory vesicles in the absence of clathrin. These vesicles can be 
distinguished by electron microscopy. If Syk-dependent signaling participates in the 
regulated exocytosis of TNFα, we might be able to observe an absence of these clathrin-
coated TNFα vesicles in the Syk-deficient cells.  
 
Syk modulates TNFα  exocytosis in response to TLR9 stimulation 
 TNFα is a potent proinflammatory cytokine exerting both beneficial and 
detrimental effects for the host. TNFα signaling is known to be essential for the 
clearance of several intracellular pathogens, including Mycobacterium tuberculosis, 
Listeria monocytogenes, Salmonella typhimurium, Leishmania, and M. avium (Hehlgans 
and Pfeffer, 2005). This cytokine can recruit other inflammatory cells, like monocytes 
and neutrophils, and enhance the killing of bacteria. However, when present in excess, 
TNFα can elicit damage to host tissues. Therefore, achieving the appropriate balance of 
TNFα production and signaling is crucial for maintaining the health and fitness of the 
host. Moreover, tight regulation of this molecule is necessary to control the balance 
between resistance and tolerance to infection. 
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 In order to maintain fitness, an infected host must adequately control an invading 
pathogen while allowing minimal damage to its own tissues. For example, 
overstimulation of inflammatory pathways can lead to severe immunopathology even 
after the pathogen has been cleared (Medzhitov et al., 2012). Therefore, inflammatory 
pathways must be downregulated while expression of mediators contributing to 
pathogen clearance without detrimental effects on the host must remain high to limit 
damage to the host while still mounting an adequate immune response. Medzhitov 
demonstrated that LPS-pretreated bone marrow derived macrophages decreased 
expression of IL-6 following LPS stimulation in vitro. Antimicrobial peptide expression 
remained active during stimulation (Foster et al., 2007). These data suggest that cells 
are capable of “turning off” proinflammatory responses after continued TLR stimulation in 
vitro. In vivo, TNFα expression in the lamina propria of the small intestine was necessary 
to control T. gondii replication, but excessive stimulation resulted in TNFα-induced 
necrosis of the small intestine (Liesenfeld et al., 1999). Administration of a TNFα 
blocking antibody diminished intestinal pathology, but parasite burdened remained high. 
Because of the dichotomous role of TNFα, completely abolishing its actions does not 
entirely protect the host. Perhaps administration of anti-TNFα in the later stages of 
infection would allow ample time for TNFα-induced control of parasite replication while 
preventing TNFα-induced pathology. However, if parasite burden is large enough to 
induce a strong proinflammatory response early in infection, then TNFα-induced 
necrosis might occur concurrently with parasite replication control.  
 A recent study linking TNFα and immunopathology highlights the dichotomous 
nature of this cytokine. Humans infected with Puumala hantavirus (PUUV) develop 
hemorrhagic fever and renal failure, associated with high levels of TNFα, even after 
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pathogen clearance. Interestingly, rodents infected with this virus developed chronic 
infection with limited host damage (Guivier et al., 2010). Infected animals exhibited no 
TNFα upregulation. Therefore, these animals are tolerant to PUUV infection likely due to 
lack of TNFα expression.  
In our system, we find that TNFα secretion was reduced two-fold in the absence 
of Syk following CpG-induced stimulation of TLR9. Interference of Syk could result in 
half the amount of serum TNFα, potentially enough to interfere with pathogen replication 
but not enough to elicit immunopathology. It will be interesting to infect the Syk flox 
CD11c Cre mice or Syk flox LysM Cre mice, resulting in myeloid-specific deletion of Syk, 
with various intracellular pathogens to investigate the physiological relevance of 
diminished, but not abolished, TNFα levels. We observe slightly greater than two-fold 
decrease in serum TNFα from CpG-injected Syk flox CD11c Cre mice compared to 
control mice (Figure 2.3). Interestingly, some groups have asked this question using 
TNFα heterozygous mice. These mice controlled replication of L. monocytogenes better 
than mice with a homozygous deletion of TNFα, but not as well as wild type mice (Amiot 
et al., 1997). This suggests that less than wild type levels of TNFα are still capable of 
interfering with bacterial replication. However, the degree of pathology on the host was 
not investigated in this study.  
The dual nature of TNFα behavior was also demonstrated in mycobacterial 
infection. TNF knockout mice or wild type mice infected with high doses of 
Mycobacterium bovis bacillus Calmette-Guerin (BCG) that secreted TNFα died despite 
being able to control bacterial replication. Conversely, wild type mice infected with BCG 
alone or with low doses of BCG-TNF controlled and survived pathogen infection (Bekker 
et al., 2000). These results suggest that immunopathology induced by TNFα is dose 
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dependent. Therefore, the absence of Syk-dependent TNFα secretion could be a 
strategy by which the host can limit pathology while still combating pathogenic stimuli. In 
this system, one might expect Syk flox CD11c Cre (or Syk flox LysM Cre) mice to control 
Mycobacterium replication similar to wild-type mice, but perhaps to limit the deleterious 
effects of TNFα signaling on the host. 
 
TNFα  blockade in autoimmune disease 
 Given the potency of TNFα’s damaging effect on host tissues, it is no surprise 
that this cytokine has been implicated in inflammatory disease. Rheumatoid arthritis (RA) 
is a disease characterized by chronic inflammation, joint damage, and bone erosion. 
Pathogenesis of RA is associated with numerous proinflammatory cytokines and 
chemokines, including TNFα, IL-6, IL-1β, and IL-8, and the production of autoantibodies 
(Moelants et al., 2013). A mouse model of collagen-induced arthritis revealed elevated 
levels of TNFα in the knee joints even before disease onset, and TNFα expression 
remained high during disease course (Palmblad et al., 2001). Blockade of TNFα early in 
disease onset ameliorated joint pathology (Joosten et al., 2008). It is evident, therefore, 
that TNFα contributes to inflammation and disease pathogenesis, so blocking its actions 
might be advantageous for controlling autoimmune disease. However, there is emerging 
evidence for the susceptibility of human autoimmune patients to infection when treated 
with TNFα blocking agents. Appropriate control of TNFα levels is crucial for balancing 
immunosuppression to combat inflammatory disease and the immunostimulatory effects 
of the immune system to control pathogenic stimuli.  
 There have been several cases reported in which RA patients receiving anti-
TNFα therapy developed leishmaniasis (Guedes-Barbosa et al., 2013). Therapeutic 
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intervention for the infection, in addition to the RA treatment, was undertaken in order to 
control Leishmania. There has also been correlation between RA patients treated with 
the TNFα blocker infliximab and development of tuberculosis (Weisman, 2002), and 
blocking TNFα in mice in a model of latent Mycobacterium infection resulted in 
reactivation of tuberculosis (Mohan et al., 2001). These studies demonstrate the 
potential harm that can ensue for the host by blocking TNFα entirely. Interfering with Syk 
activity in RA patients could result in about a fifty percent reduction in TNFα levels, 
potentially leaving behind enough cytokine to combat infection while blocking enough to 
ameliorate autoimmune pathogenesis. Therefore, clinically available Syk inhibitors might 
work best in patients who already respond to anti-TNFα therapy; instead of completely 
blocking TNFα signaling, one can reduce the amount of circulating TNFα by half. It will 
be important to test TNF heterozygous mice or the Syk flox CD11c Cre mice in mouse 
models of arthritis to establish the effects of diminished TNFα levels on disease 
pathogenesis and potential susceptibility to infection. Indeed, Cliff Lowell’s group 
demonstrated that neutrophil or myeloid-specific deletion of Syk blocked the progression 
of arthritis in a serum transfer model, based on joint inflammation (Elliott et al., 2011). 
However, susceptibility to pathogenic infection was not investigated in this study, but the 
results suggest that Syk deletion is effective in preventing disease. It will be useful to 
determine whether Syk blockade after disease onset is a successful therapeutic in this 
model.  
 Interestingly, two human trials of Syk inhibition for the treatment of RA yielded 
opposite results. The first trial reported significant improvement of patients receiving Syk 
inhibitor (Weinblatt et al., 2010), while a later trial revealed no significant differences 
between patients receiving the Syk inhibitor and patients receiving the placebo 
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(Genovese et al., 2011). The differences in these outcomes could be attributable to the 
patients’ treatments. The first study, in which patients reported improvements using the 
Syk inhibitor, enrolled any patients who had been on long-term immunosuppressive 
drugs. The trial in which Syk inhibition did not work only enrolled patients who had 
already failed TNFα-blocking treatments. Perhaps the patients more likely to respond to 
Syk inhibitors are those who respond to TNFα blockers, since we have now 
demonstrated that one of the effects of Syk inhibition is a 50% reduction in secreted 
TNFα. In the case of the successful trial, TNFα blockade responsive patients would 
have been included in enrollment and, therefore, would likely respond to Syk inhibition. 
In contrast, all the patients enrolled in the second trial were, by definition, TNFα 
blockade unresponsive. Therefore, Syk inhibition and the resultant decrease in TNFα 
would not be expected to have a therapeutic effect. Thus, our data may provide a basic 
biologic explanation for the divergent results of these two trials.  
 Diabetes is a disease characterized by obesity that progressively leads to 
inflammation in the visceral adipose tissue.  The inflammatory environment here 
contributes to insulin resistance and disease progression. Interestingly, mice 
heterozygous for the enzyme that cleaves membrane TNFα, TACE, were resistant to 
high fat diet induced obesity (Serino et al., 2007). Tace+/- mice on a high fat diet had 
significantly lower blood glucose levels compared to wild type mice on the same diet. 
Moreover, this group reported a fifty percent reduction in conversion of full-length TNFα 
to soluble, secreted TNFα in liver cells of Tace+/- mice compared to control mice. 
However, because TACE has substrates other than TNFα, including the IL-6 receptor 
and epidermal growth factor (EGF) receptor, it cannot be ruled out that a decrease in 
these molecules contributes to obesity prevention. Similarly, this study did not 
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investigate the effects of a high fat diet on TNFα knockout mice or TNFα heterozygous 
mice. Nonetheless, the data reported suggest that a decrease in TNFα signaling could 
contribute to a reduction in diabetes pathogenesis. Because TACE heterozygosity was 
enough to limit disease pathology, perhaps the fifty percent reduction in serum TNFα 
due to Syk deletion in the Syk flox CD11c Cre mice will be enough to lower blood 
glucose levels in a model of diet-induced obesity and diabetes. Moreover, it will be 
interesting to investigate the effects of reduced TNFα in such a model on accompanying 
pathogenic infection. 
 
Syk mediates CpG-induced MCP-1 secretion 
 MCP-1 is a chemokine upregulated early during pathogen infection and can 
contribute to inflammation through its recruitment of inflammatory cells like monocytes to 
the site of infection (Ajuebor et al., 1998). We observe that Syk deletion impairs the 
secretion of MCP-1 in macrophages following CpG stimulation. Similar to the 
dichotomous nature of TNFα, MCP-1 can also exert both positive and negative effects 
on the host during the course of an immune response. Through its recruitment of 
inflammatory cells into the inflamed tissue, MCP-1 can contribute to pathogen replication 
control and clearance. However, excessive amounts of chemokine can result in host 
tissue damage. Blocking MCP-1 in a model of influenza infection resulted in decreased 
pathology in the lungs (Damjanovic et al., 2011). Furthermore, MCP-1 levels remained 
elevated during respiratory syncytial virus (RSV) infection and lead to lung tissue 
damage (Culley et al., 2006). Inhibiting the actions of Syk could be a mechanism by 
which to decrease MCP-1 levels without completely abolishing its expression, thereby 
allowing this chemokine to function appropriately during pathogenic infection.  
	  
	  
76	  
Broad tyrosine kinase inhibition to diminish TLR signaling 
 In this thesis, we have investigated the role of tyrosine phosphorylation in TLR9 
biology. The canonical signaling molecules described in TLR function have been 
serine/threonine kinases. Investigating the role of tyrosine kinases will uncover new 
biochemical mechanisms mediating TLR function and will provide a new class of 
molecules to target for therapeutic intervention. As discussed above, our data 
demonstrate that the protein tyrosine kinase Syk modulates TNFα and MCP-1 
exocytosis in macrophages and DCs in response to CpG. In Chapter IV, we investigated 
how a conserved tyrosine in box 1 of the TIR domain affects TLR9 signaling. Though 
preliminary, our data suggest that tyrosine 870 mediates receptor maturation. Because 
mutation to phenylalanine resulted in a partial defect of TLR9 maturation, it is possible 
that phosphorylation of that tyrosine is important for this process. However, future 
studies are needed to confirm this hypothesis. If tyrosine phosphorylation mediates 
receptor maturation, then broad tyrosine kinase inhibition would result in abrogation of 
TLR responses. Conversely, inhibition of Syk would have a more specific effect, 
diminished secretion of a subset of cytokines.  
 Because tyrosine kinases are associated with such diverse cellular processes, 
including cell proliferation, metabolic function, and differentiation, dysregulation of this 
class of molecules is associated with malignant and non-malignant disorders 
(Grimminger et al., 2010). Indeed, several drugs have been developed to inhibit these 
molecules for treatment of a variety of disorders, including malignancy, pulmonary 
vascular disease, lung fibrosis, sclerosis, and kidney disease, among others 
(Grimminger et al., 2010). Tyrosine kinase inhibition also prevented lethality in a mouse 
model of LPS-induced sepsis (Novogrodsky et al., 1994). Treatment was associated with 
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reduced levels of TNFα and reactive oxygen species in vivo, providing another link 
between tyrosine phosphorylation events and TLR function. It is evident that disruption 
of the activity of these molecules can lead to a variety of physiological outcomes that can 
result in therapeutic relief. However, because pharmacological inhibition of kinases has 
been linked to off-target effects and undesired side effects, it is imperative that the 
function of these kinases are scrutinized in various cellular processes.  
 As noted above, broad tyrosine kinase inhibition would result in disruption of 
TLR9 signaling, if tyrosine phosphorylation is involved in receptor maturation. Therefore, 
treatment of a condition like RA, for example, with a broad tyrosine kinase inhibitor 
would likely result in a complete loss of TLR signaling, whereas Syk inhibition would lead 
to diminished TNFα secretion, a cytokine implicated in pathogenesis of this disease, 
while preserving other TLR functions. Cytokines impart different effector functions on the 
developing immune response. Therefore, more selective inhibition is useful for disrupting 
a specific cytokine response. Understanding how these responses are regulated is 
critical for the development of more specific drugs. Additionally, broad tyrosine kinase 
inhibition could potentially disrupt other signaling cascades required for normal 
homeostasis in the host. In the case of cytokine storm, however, broader inhibition was 
necessary to prevent signaling of a variety of inflammatory mediators that contribute to 
host destruction (Novogrodsky et al., 1994). Excessive TLR9 signaling induced cytokine 
storm in a mouse model of macrophage activation syndrome (MAS), while TLR9 KO 
mice were protected from disease (Behrens et al., 2011). Tyrosine kinase inhibition 
might represent a way to limit the pathology induced by the numerous cytokines, 
including IL-6, IL-12, and IFNγ, associated with disease and offer therapeutic relief. 
Furthermore, we can test if the TLR9 Y870F or Y870A mutants reduce disease severity. 
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For these experiments, we can generate bone marrow chimeras by reconstituting TLR9 
KO mice with TLR9 deficient bone marrow transduced with either TLR9 Y870F or Y870A 
and by subjecting the recipient mice to CpG-induced MAS.  
TLR9 tyrosine phosphorylation has been reported previously, and this 
phosphorylation was abrogated with Src family and Syk kinase inhibitors (Sanjuan et al., 
2006). However, because of the off-target effects reported of these drugs (Geahlen and 
McLaughlin, 1989), more rigorous investigation is needed to determine the mechanism 
by which TLR9 is phosphorylated. Because Syk deletion results in normal CpG-induced 
MAPK and NF-κB activation, canonical TLR9 signaling intermediates (see Figure 2.8), it 
is unlikely that Syk is the kinase responsible for TLR9 phosphorylation in our system. To 
confirm this, we can express TLR9-HA in bone marrow from the Syk flox CD11c Cre 
mice and assess receptor phosphorylation and maturation in differentiated DCs.  
Furthermore, our data demonstrate reduced expression of mature TLR9 when tyrosine 
870 is mutated to phenylalanine. It is likely, therefore, that this mutant exhibits abrogated 
activation of the canonical signaling pathway compared to the wild type receptor, in 
contrast to what was observed with the Syk-deficient cells. This will be important to 
confirm experimentally. Additional work is needed to determine the kinase mediating 
TLR9 phosphorylation. 
 
Conclusions 
 The work presented here describes the regulation of TLR9 function by tyrosine 
kinases. Because TLR recognition triggers powerful immune responses against invading 
pathogens, understanding the biochemical mechanisms by which these responses are 
generated will provide insight into how these receptors meditate pathogen recognition  
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and host defense. Tyrosine kinases represent a class of molecules that can be targeted 
to control the immune response. Understanding their functions will enable the design of 
effective therapies with limited side effects.  
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Appendix I  
Abbreviations 
A 
Ala, alanine 
 
B 
BCG, Mycobacterium bovis bacillus Calmette-Guerin 
BMDC, bone marrow derived dendritic cell 
BTK, Bruton’s tyrosine kinase 
 
C 
Ca2+, calcium 
CaMKII, Ca2+/calmodulin-dependent kinase II 
 
D 
DC, dendritic cell 
 
E 
EGF, epidermal growth factor 
ER, endoplasmic reticulum 
Erk, extracellular signal-related kinase 
 
G 
GPI, glycosylphosphatidylinositol 
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H 
HSV-1, herpes simplex virus-1 
 
I 
IFN, interferon 
IKK, IκB kinase 
IL, interleukin 
IRAK, interleukin-1 receptor associated kinase 
IRF, interferon regulatory factor 
ITAM, immunoreceptor tyrosine-based activation motif 
 
J 
JNK, c-Jun terminal kinase 
 
K 
KO, knockout  
 
L 
LPS, lipopolysaccharide 
 
M 
MAPK, mitogen activated protein kinase 
MAS, macrophage activation syndrome 
MCMV, mouse cytomegalovirus 
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MCP-1, monocyte chemoattractant protein-1 
MD-2, myeloid differentiation factor-2 
MHC, major histocompatibility complex  
MIP-1α, macrophage inflammatory protein-1 alpha 
mmLDL, minimally oxidized low-density lipoprotein  
MyD88, myeloid differentiation factor-88 
 
N 
NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells 
NSF, N-ethylmaleimide-sensitive factor 
 
P 
PAMP, pathogen-associated molecular pattern 
Phe, phenylalanine 
PLCγ, phospholipase C gamma 
PI3K, phosphoinositide kinase-3 
PRR, pattern recognition receptor 
Pyk2, proline rich kinase-2 
PUUV, Puumala hantavirus 
 
R 
RA, Rheumatoid arthritis 
ROS, reactive oxygen species 
RSV, respiratory syncytial virus 
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S 
SCAMP5, secretory carrier membrane protein-5 
SLP-65, SH2 domain containing leukocyte protein of 65 kilodaltons 
SNARE, soluble NSF attachment protein receptor 
Syk, spleen tyrosine kinase 
 
T 
TACE, TNFα-converting enzyme 
TAK1, transforming growth factor-β-activated protein kinase-1 
TIR, toll interleukin-1 receptor and resistance protein 
TIRAP, TIR domain-containing adaptor protein 
TLR, toll-like receptor 
TNF, tumor necrosis factor alpha 
TRAF6, tumor necrosis factor receptor-associated factor-6 
TRAM, TRIF-related adaptor molecule 
TRIF, TIR domain-containing adaptor inducing IFNβ 
Tyr, tyrosine 
 
V 
VAMP, vesicle associated membrane protein 
 
W 
WT, wild type 
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Appendix II 
Materials and Methods 
 
Chapter II 
Mice  
Sykflox/floxCD11c Cre+ and Sykflox/flox CD11c Cre negative mice were housed in our 
AAALAC certified animal facility. Mice were used in experiments between 7 and 10 
weeks of age. All experiments were performed with approval of the The Children's 
Hospital of Philadelphia IACUC. 
 
Antibodies and reagents 
The following Western blot antibodies were used from Cell Signaling: TNFα (#3707), 
phospho-ERK (clone D13.14.4E), total ERK (clone L34F12), phospho-p38 (clone 
28B10), NF-κB p65 (clone C22B4), and IκBα (clone 44D4). 
The following Western blot antibodies were purchased from Santa Cruz: β-actin (clone 
C-11), Syk (clone N-19), and MHC classII (clone M5/114). Secondary antibodies 
(mouse, goat, rat, and rabbit IgG) were purchased from Licor. Antibodies used for flow 
cytometry from BD Biosciences include TNFα (clone MP6-XT22) conjugated to AF-700 
or Pe-Cy7 and CD11c (clone HL3) conjugated to APC or Pe-Cy7.  
TAPI-0 (20µM; EMD Millipore) was used to inhibit TACE activity and thus prevent 
cleavage of surface TNFα. 
 
Cell culture and lentiviral transduction 
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The mouse RAW264.7 macrophage cell line was cultured in DMEM (Invitrogen) 
containing 10% heat-inactivated fetal bovine serum (Atlanta Biologicals) and antibiotic 
(penicillin, streptomycin, and glutamine; Invitrogen) at 37 degrees in a 5% CO2 
incubator. For experiments, cells were stimulated with 10µg/ml CpG1826 (IDT).  
 Lentivirus containing the pLKO.1 vector expressing Syk shRNA (Open 
Biosystems) was made using the calcium phosphate method of transfection of HEK293 
T cells and then transduced into RAW cells. Briefly, 0.2 million RAW cells were plated on 
24-well sterile tissue culture treated plates (Cell Star) and allowed to attach overnight. 
On day 1 after plating, 1ml of viral supernatant was added to each well in the presence 
of polybrene (4µg/ml), and plates were centrifuged for 2 hours at 2000rpm at 32 
degrees, and cells were returned to the incubator with fresh DMEM. Transduction was 
repeated on day 2. On day 4, puromycin (2µg/ml; Sigma) was added to the culture to 
select for virally-transduced cells. Protein knockdown was assessed by Western blotting.  
 
Preparation of mouse BMDCs 
Bone marrow was flushed from the tibias and femurs of control and Syk flox mice and 
cultured for 8 days in IMDM medium (Invitrogen) containing antibiotics (penicillin, 
streptomycin, and glutamine), fetal bovine serum, and GM-CSF (3.3ng/ml; Peprotech). 
On day 8, cells were stimulated with CpG for various assays. 
 
Preparation of splenic DCs 
Control and Syk flox mice were injected sub-cutaneaously with 5 million B16-Flt3L cells. 
This melanoma cell line is genetically engineered to secrete Flt3L. Fourteen days post-
injection, mice were sacrificed and spleens were treated with DNase (50µg/ml; Roche) 
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and Collagenase (100µg/ml; Roche) for 30 minutes at 37 degrees. Splenocytes were 
harvested, and DCs were selected with magnetic CD11c beads (Miltenyi Biotec) run 
through a MACS LS column (Miltenyi Biotec). Purity was confirmed using flow cytometry. 
CD11c+ splenic DCs were cultured in complete IMDM medium containing 10ng/ml GM-
CSF. 
 
Cytokine Secretion Measurements 
After stimulation of cultured cells with CpG, supernatants were collected and centrifuged 
for 10 minutes at 13,200rpm at 4 degrees. Cytokine concentrations were measured in 
the supernatants using TNFα, IL-6, and MCP-1 ELISA kits (BD OptEIA, BD) according to 
the manufacturer’s instructions. For detection of serum TNFα from CpG-injected control 
and Syk flox mice, blood was collected from the cheek vein and centrifuged for 20 
minutes at 13,200rpm. Serum was tested using an ELISA kit.  
 
Flow Cytometry 
For detection of surface TNFα, cultured cells stimulated with CpG and TAPI-0 were 
harvested, pelleted, and resuspended in FACS buffer (PBS containing 2% fetal bovine 
serum and 0.01% sodium azide). Cells were then resuspended sequentially in 4% 
paraformaldehyde (20 min) and Pe-Cy7-conjugated rat anti-TNF antibody (BD). For 
detection of intracellular TNFα, cultured cells were stimulated with CpG in the presence 
of Brefeldin-A, which prevents transport of newly synthesized proteins from the 
endoplasmic reticulum. After harvesting, cells were fixed and permeabilized for 20 
minutes with 1x cytofix/cytoperm (BD). Cells were washed in 1x Permwash (BD) and 
stained with Pe-Cy7 or AF700-conjugated rat anti-TNF antibody (BD). All steps were 
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performed at 4 degrees. Cells were analyzed on a LSR II (BD) using FACSDiva 
software, and data were analyzed using FlowJo software (TreeStar). 
 
Western blotting and TACE activity assay 
For preparation of whole cell lysate, cells were washed in cold PBS and lysed in 1% 
NP40 buffer containing 5M NaCl, 1M Tris (pH 7.4), complete protease inhibitor cocktail 
(Sigma), 100mM NaF, 100mM NaVanadate, and 100mM phenylmethanesulfonylflouride. 
Lysates were centrifuged for 10 minutes at 13,200 rpm and stored at -20 degrees. For 
preparation of membrane lysates, cells were washed in cold PBS and resuspended in 
PBS containing protease and phosphatase inhibitors. Cells underwent 5 cycles of 
freeze/thaw lysis, frozen in an ethanol/dry ice bath and thawed in a 37 degree water 
bath. Lysates were centrifuged at 20,000g for 15 minutes. Pellets (membrane fraction) 
were washed in PBS and centrifuged again and resuspended in 1% NP40 lysis buffer. 
To obtain nuclear lysates to investigate nuclear translocation of NF-κB, CpG-stimulated 
cells were lysed using the NE-PER Nuclear and Cytoplasmic Extraction Kit (Thermo 
Scientific) according to the manufacturer’s instructions. All lysates were boiled and 
separated on SDS-PAGE (4% Bis-Tris gel; Invitrogen) and analyzed by Western blotting. 
Licor software of analysis was used to analyze blots developed on Odyssey. 
 Membrane lysates were also plated on a black 96-well plate for the Sensolyte 
520 TACE Activity Assay (Anaspec) according to the manufacturer’s instructions. Briefly, 
a peptide substrate, the fluorescence of which was quenched in the intact peptide, was 
added to lysates. In the presence of TACE, the peptide was cleaved, and fluorescence, 
which was directly proportional to the amount of TACE activity, of the cleaved substrate 
was measured. 
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Preparation of RNA for Real-time PCR 
RNA was isolated from cultured cells using the RNeasy Kit (Qiagen) according to the 
manufacturer’s instructions, and cDNA was synthesized using the SuperScript III kit 
(Invitrogen) from 1µg RNA. qPCR was performed on the cDNA using TaqMan Gene 
Expression Assays (Applied Biosystems), with probes for mouse TNFα 
(Mn00443258_m1), mouse TLR9 (Mn00446193_m1), and mouse GAPDH 
(Mn99999915_g1). Samples were run and analyzed using Sequence Detection System 
7500 PCR machine from Applied Biosystems. TNFα message levels and TLR9 message 
levels were normalized to that of GAPDH.  
 
Statistical Analysis 
Graphs and statistical tests were generated and analyzed using Prism Version 5.0. In 
general, the unpaired t test was used to compare groups. To analyze membrane TNFα 
data, membrane TNFα was normalized to MHC class II for each cell type. The relative 
amount of membrane TNFα was computed by dividing normalized TNFα of the Syk-
deficient cells to that of the control cells. The resulting ratio was compared to the value 
of 1 representing no change using a one sample t test. Similarly, the MFI of surface 
TNFα was compared between Syk-deficient and control cells, and the resulting ratio was 
analyzed against the value of 1. 
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Chapter III 
 
Antibodies and reagents 
The following Western blot antibodies were used from Cell Signaling: phospo-CaMKII 
(#3361), pan CaMKII (clone D11A10), and PLCγ2 (#3872). β-actin (clone C-11) was 
purchased from Santa Cruz. Secondary antibodies (mouse, goat, rat, and rabbit IgG) 
were purchased from Licor. Antibodies used for flow cytometry from BD Biosciences 
include TNFα (clone MP6-XT22) conjugated to AF-700. 
Ionomycin (Molecular Probes) was used at 1µg/ml. BAPTA-AM was purchased from 
Sigma. 
 
Cell culture and lentiviral transduction 
The mouse RAW264.7 macrophage cell line was cultured in DMEM (Invitrogen) 
containing 10% heat-inactivated fetal bovine serum (Atlanta Biologicals) and antibiotic 
(penicillin, streptomycin, and glutamine; Invitrogen) at 37 degrees in a 5% CO2 
incubator. For experiments, cells were stimulated with 10µg/ml CpG1826 (IDT).  
 Lentivirus containing the pLKO.1 vector expressing PLCγ2 shRNA or CaMKII 
shRNA (Open Biosystems) was made using the calcium phosphate method of 
transfection of HEK293 T cells and then transduced into RAW cells. Briefly, 0.2 million 
RAW cells were plated on 24-well sterile tissue culture treated plates (Cell Star) and 
allowed to attach overnight. On day 1 after plating, 1ml of viral supernatant was added to 
each well in the presence of polybrene (4µg/ml), and plates were centrifuged for 2 hours 
at 2000rpm at 32 degrees, and cells were returned to the incubator with fresh DMEM. 
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Transduction was repeated on day 2. On day 4, puromycin (2µg/ml; Sigma) was added 
to the culture to select for virally-transduced cells. Protein knockdown was assessed by 
Western blotting.  
 
Preparation of mouse BMDCs 
Bone marrow was flushed from the tibias and femurs of control and Syk flox mice and 
cultured for 8 days in IMDM medium (Invitrogen) containing antibiotics (penicillin, 
streptomycin, and glutamine), fetal bovine serum, and GM-CSF (3.3ng/ml; Peprotech). 
On day 8, cells were stimulated with CpG for various assays. 
 
Flow cytometry 
For detection of intracellular TNFα, cultured cells were stimulated with CpG in the 
presence of Brefeldin-A, which prevents transport of newly synthesized proteins from the 
endoplasmic reticulum. After harvesting, cells were fixed and permeabilized for 20 
minutes with 1x cytofix/cytoperm (BD). Cells were washed in 1x Permwash (BD) and 
stained with Pe-Cy7 or AF700-conjugated rat anti-TNF antibody (BD). All steps were 
performed at 4 degrees. Cells were analyzed on a LSR II (BD) using FACSDiva 
software, and data were analyzed using FlowJo software (TreeStar). 
 
Intracellular Calcium Measurements 
RAW cells were loaded with fura-2 AM (3µM; Invitrogen) for 45 minutes at room 
temperature, and intracellular calcium was detected in response to CpG by digital 
imaging as previously described (Liu et al., 2002). The fluorescence emission ratio of 
fura-2 was detected at 510nm in a solution containing no calcium to establish a baseline 
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reading. CpG was added before the cells were returned to a bath solution containing 
155mM NaCl, 4.5mK KCl, 2mM CaCl2, 1mM MgCl2, 5mM glucose, 10mM HEPES, pH 
7.4. Cells were then stimulated with ATP (10µM) and Ionomycin.  
 
Western blotting  
For preparation of whole cell lysate, cells were washed in cold PBS and lysed in 1% 
NP40 buffer containing 5M NaCl, 1M Tris (pH 7.4), complete protease inhibitor cocktail 
(Sigma), 100mM NaF, 100mM NaVanadate, and 100mM phenylmethanesulfonylflouride. 
Lysates were centrifuged for 10 minutes at 13,200 rpm and stored at -20 degrees. All 
lysates were boiled and separated on SDS-PAGE (4% Bis-Tris gel; Invitrogen) and 
analyzed by Western blotting. Licor software of analysis was used to analyze blots 
developed on Odyssey. 
 
Statistical Analysis 
Graphs and statistical tests were generated and analyzed using Prism Version 5.0. In 
general, the unpaired t test was used to compare groups. For studies involving calcium 
signaling, pCaMKII was normalized to total ERK for each cell genotype. Data were 
analyzed based on fold induction from baseline (comparison of normalized pCaMKII at 
each timepoint of stimulation to that at baseline) and based on percentage of Ionomycin 
(comparison of untreated, 30 minutes CpG, and 60 minutes CpG to Ionomycin).  
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Chapter IV 
Mice 
TLR9 KO mice were housed in our AAALAC certified animal facility. Mice were used in 
experiments between 7 and 10 weeks of age. All experiments were performed with 
approval of the University of Pennsylvania IACUC. 
 
Antibodies and reagents 
Rabbit HA (clone C29F4) and mouse total Erk (clone L34F12) were purchased from Cell 
Signaling. Secondary antibodies (mouse and rabbit IgG) were purchased from Licor. 
Antibodies used for flow cytometry from BD Biosciences include TNFα (clone MP6-
XT22) conjugated to AF-700, IL-6 (clone MP5-20F3) conjugated to PE, and CD11c 
(clone HL3) conjugated to PeCy7. HA (clone 6E2) conjugated to Alexa Fluor 647 was 
purchased from Cell Signaling. 
 
Cloning 
pUNO-mTLR9-HA was purchased from InvivoGen. Tyrosine 870 of TLR9 was mutated 
to either a phenylalanine (Y870F) or alanine (Y870A) using the QuikChange Lightning 
Site-Directed Mutagensis Kit (Agilent Technologies) according to the manufacturer’s 
instructions. The following primers were used. Y870F Forward: 5’-
CGCCCAAACTCTCCCTTTTGATGCCTTCGTGG-3’; Y870F Reverse: 5’-
CCACGAAGGCATCAAAAGGGAGAGTTTGGGCG-3’ ; Y870A Forward: 5’-
GCAGCGCCCAAACTCTCCCTGCTGA-3’ ; Y870A Reverse: 5’-
CACGAAGGCATCAGCAGGGAGAGTT-3. The primer used for sequencing TLR9 was 
5’-TGCTTTGGCCTTTCACTCTT-3’. WT-TLR9-HA, TLR9 Y870F-HA, and TLR9 Y870A-
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HA were cut from the pUno vector with the restriction enzymes Age1 and Hpa1 (New 
England Biolabs) and sub-cloned into the MigR retrovirus multiple cloning site (MCS) 
upstream of the internal ribosomal entry site. For this, Age1 was inserted into the MCS 
of MigR using a BglII-Age1-Hpa1 linker.  
 
Culture and retroviral transduction of mouse BMDCs 
Bone marrow was flushed from the tibias and femurs of TLR9 KO mice and cultured for 
10 days in IMDM medium (Invitrogen) containing antibiotics (penicillin, streptomycin, and 
glutamine), 10% fetal bovine serum, and GM-CSF (3.3ng/ml; Peprotech). MigR 
retrovirus expressing WT TLR9, TLR9 Y870F, or TLR9 Y870A was constructed using 
the calcium phosphate method of transfection into HEK293 T cells. On days 2 and 3 of 
bone marrow culture, cells were transduced with retrovirus. Briefly, viral supernatant 
containing 4µg/ml polybrene was added to cells in a 24 or 6-well plate, and plates were 
centrifuged for 2 hours at 2000rpm at 32 degrees Celsius. Transduction was assessed 
by GFP expression (flow cytometry) or by HA expression (flow cytometry and Western 
blot).  
 
Cytokine Secretion Measurements 
After stimulation of cultured BMDCs with CpG (1µg/ml), supernatants were collected and 
centrifuged for 10 minutes at 13,200rpm at 4 degrees. Cytokine concentrations were 
measured in the supernatants using TNFα and IL-6 ELISA kits (BD OptEIA, BD) 
according to the manufacturer’s instructions.  
 
Western blotting  
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For preparation of whole cell lysate, cells were washed in cold PBS and lysed in 1% 
NP40 buffer containing 5M NaCl, 1M Tris (pH 7.4), complete protease inhibitor cocktail 
(Sigma), 100mM NaF, 100mM NaVanadate, and 100mM phenylmethanesulfonylflouride. 
Lysates were centrifuged for 10 minutes at 13,200 rpm and stored at -20 degrees. All 
lysates were boiled and separated on SDS-PAGE (4% Bis-Tris gel; Invitrogen) and 
analyzed by Western blotting. Licor software of analysis was used to analyze blots 
developed on Odyssey. 
 
Flow cytometry 
For detection of surface CD11c, cells were washed, pelleted and resuspended in FACS 
buffer (PBS containing 2% fetal bovine serum and 0.01% sodium azide). Cells were then 
incubated with CD11c antibody conjugated to PeCy7. For detection of intracellular 
cytokines and HA, cells stimulated with CpG in the presence of Brefeldin-A were fixed 
and permeablized with 1x cytofix/cytoperm (BD) for 20 minutes. Cells were washed with 
1x permwash (BD) and stained with TNF antibody conjugated to AF-700, IL-6 antibody 
conjugated to PE, and HA antibody conjugated to AF-647. All steps were performed at 4 
degrees. Cells were analyzed on a LSR II (BD) using FACSDiva software, and data 
were analyzed using FlowJo software (TreeStar). 
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